Search
Carboplatin Treatment Options in Canada
A collection of 335 research studies where Carboplatin is the interventional treatment. These studies are located in the Canada . Carboplatin is used for conditions such as Non-Small Cell Lung Cancer, Ovarian Cancer and Lung Cancer.
25 - 36 of 335
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Recruiting
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1).
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Research Site, Tucson, Arizona +290 locations
Research Site, Tucson, Arizona
Research Site, Springdale, Arkansas
Research Site, Beverly Hills, California
Research Site, Glendale, California
Research Site, Los Alamitos, California
Research Site, Redlands, California
Research Site, San Francisco, California
Research Site, Walnut Creek, California
Research Site, West Haven, Connecticut
Research Site, Newark, Delaware
Research Site, Bay Pines, Florida
Research Site, Fort Lauderdale, Florida
Research Site, Gainesville, Florida
Research Site, Gainesville, Florida
Research Site, Jacksonville, Florida
Research Site, Athens, Georgia
Research Site, Atlanta, Georgia
Research Site, Boise, Idaho
Research Site, Chicago, Illinois
Research Site, Decatur, Illinois
Research Site, Hinsdale, Illinois
Research Site, Quincy, Illinois
Research Site, Waterloo, Iowa
Research Site, Lexington, Kentucky
Research Site, Lexington, Kentucky
Research Site, Louisville, Kentucky
Research Site, Louisville, Kentucky
Research Site, Alexandria, Louisiana
Research Site, Baton Rouge, Louisiana
Research Site, Covington, Louisiana
Research Site, Shreveport, Louisiana
Research Site, Shreveport, Louisiana
Research Site, South Portland, Maine
Research Site, Baltimore, Maryland
Research Site, Bethesda, Maryland
Research Site, Detroit, Michigan
Research Site, Grand Rapids, Michigan
Research Site, Duluth, Minnesota
Research Site, Rochester, Minnesota
Research Site, Bridgeton, Missouri
Research Site, Columbia, Missouri
Research Site, Kansas City, Missouri
Research Site, Lincoln, Nebraska
Research Site, Camden, New Jersey
Research Site, Buffalo, New York
Research Site, East Syracuse, New York
Research Site, Westbury, New York
Research Site, Cincinnati, Ohio
Research Site, Bend, Oregon
Research Site, Medford, Oregon
Research Site, Salem, Oregon
Research Site, Hershey, Pennsylvania
Research Site, York, Pennsylvania
Research Site, Sioux Falls, South Dakota
Research Site, Chattanooga, Tennessee
Research Site, Nashville, Tennessee
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Kingwood, Texas
Research Site, Lubbock, Texas
Research Site, Round Rock, Texas
Research Site, Fairfax, Virginia
Research Site, Fredericksburg, Virginia
Research Site, Olympia, Washington
Research Site, Seattle, Washington
Research Site, Silverdale, Washington
Research Site, Spokane, Washington
Research Site, Tacoma, Washington
Research Site, Wenatchee, Washington
Research Site, Buenos Aires, Not set
Research Site, Caba, Not set
Research Site, La Plata, Not set
Research Site, Pilar, Not set
Research Site, Rosario, Not set
Research Site, Darlinghurst, Not set
Research Site, Hyde Park, Not set
Research Site, Southport, Not set
Research Site, Wollongong, Not set
Research Site, Innsbruck, Not set
Research Site, Krems, Not set
Research Site, Rankweil, Not set
Research Site, Wien, Not set
Research Site, Wien, Not set
Research Site, Anderlecht, Not set
Research Site, Brussels, Not set
Research Site, Charleroi, Not set
Research Site, Kortrijk, Not set
Research Site, Ottignies, Not set
Research Site, Sint-Niklaas, Not set
Research Site, Barretos, Not set
Research Site, Florianópolis, Not set
Research Site, Ijuí, Not set
Research Site, Londrina, Not set
Research Site, Porto Alegre, Not set
Research Site, Salvador, Not set
Research Site, Sao Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Taubaté, Not set
Research Site, Saint John, New Brunswick
Research Site, Sydney, Nova Scotia
Research Site, Hamilton, Ontario
Research Site, Sault Ste. Marie, Ontario
Research Site, Montréal, Quebec
Research Site, Montréal, Quebec
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changchun, Not set
Research Site, Changde, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Dalian, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Harbin, Not set
Research Site, Hefei, Not set
Research Site, Hefei, Not set
Research Site, Jinan, Not set
Research Site, Kunming, Not set
Research Site, Linhai, Not set
Research Site, Linyi, Not set
Research Site, Nanchang, Not set
Research Site, Ningbo, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Shenzhen, Not set
Research Site, Taiyuan, Not set
Research Site, Tianjin, Not set
Research Site, Wenzhou, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Yangzhou, Not set
Research Site, Yueyang, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Avignon, Not set
Research Site, La Rochelle Cedex, Not set
Research Site, Lyon, Not set
Research Site, Nimes, Not set
Research Site, Rennes, Not set
Research Site, Strasbourg Cedex, Not set
Research Site, Suresnes, Not set
Research Site, Toulon Cedex 9, Not set
Research Site, Bad Berka, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Esslingen, Not set
Research Site, Frankfurt, Not set
Research Site, Gauting, Not set
Research Site, Gießen, Not set
Research Site, Großhansdorf, Not set
Research Site, Hamburg, Not set
Research Site, Hannover, Not set
Research Site, Hannover, Not set
Research Site, Heidelberg, Not set
Research Site, Hemer, Not set
Research Site, Homburg, Not set
Research Site, Kassel, Not set
Research Site, Kiel, Not set
Research Site, Krefeld, Not set
Research Site, Köln, Not set
Research Site, Minden, Not set
Research Site, Moers, Not set
Research Site, München, Not set
Research Site, Regensburg, Not set
Research Site, Würzburg, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Debrecen, Not set
Research Site, Gyöngyös, Not set
Research Site, Győr, Not set
Research Site, Pécs, Not set
Research Site, Székesfehérvár, Not set
Research Site, Törökbálint, Not set
Research Site, Calicut, Not set
Research Site, Delhi, Not set
Research Site, Kolkata, Not set
Research Site, Madurai, Not set
Research Site, Mumbai, Not set
Research Site, Nashik, Not set
Research Site, New Delhi, Not set
Research Site, Pondicherry, Not set
Research Site, Surat, Not set
Research Site, Varanasi, Not set
Research Site, Firenze, Not set
Research Site, Monza, Not set
Research Site, Orbassano, Not set
Research Site, Padova, Not set
Research Site, Peschiera Del Garda, Not set
Research Site, Roma, Not set
Research Site, Amagasaki-shi, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Kawagoe-shi, Not set
Research Site, Kitaadachi-gun, Not set
Research Site, Kitakyushu-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Koto-ku, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Matsusaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osakasayama, Not set
Research Site, Ota-shi, Not set
Research Site, Saitama-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Cheongju-si, Not set
Research Site, Incheon, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Suwon-si, Not set
Research Site, George Town, Not set
Research Site, Johor Bahru, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Alkmaar, Not set
Research Site, Ede, Not set
Research Site, Groningen, Not set
Research Site, Leidschendam, Not set
Research Site, Veldhoven, Not set
Research Site, Zwolle, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Biała Podlaska, Not set
Research Site, Białystok, Not set
Research Site, Bydgoszcz, Not set
Research Site, Bystra, Not set
Research Site, Poznań, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, San Juan, Not set
Research Site, San Juan, Not set
Research Site, Barcelona, Not set
Research Site, Las Palmas de Gran Canaria, Not set
Research Site, Lérida, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Majadahonda, Not set
Research Site, Sevilla, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, New Taipei, Not set
Research Site, New Taipei, Not set
Research Site, Taichung, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Taoyuan, Not set
Research Site, Bangkok, Not set
Research Site, Chiang Mai, Not set
Research Site, Dusit, Not set
Research Site, Nakhon Ratchasima, Not set
Research Site, Songkla, Not set
Research Site, Antalya, Not set
Research Site, İstanbul, Not set
Research Site, Yenimahalle, Not set
Research Site, Aberdeen, Not set
Research Site, Cambridge, Not set
Research Site, Edinburgh, Not set
Research Site, Exeter, Not set
Research Site, Greater London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Manchester, Not set
Research Site, Newcastle upon Tyne, Not set
Research Site, Preston, Not set
Research Site, Can Tho, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh City, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Vinh, Not set
Conditions: Non-small Cell Lung Cancer
A Study to Learn More About How Well Sevabertinib (BAY 2927088) Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Recruiting
Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor receptor 2 (HER2) mutations.
Advanced NSCLC is a group of lung cancers that have spread to nearby tissues or to other parts of the body or that are unlikely to be cured or controlled with currently available treatments. HER2 is a protein that helps cells to grow and divide. A damage (also called mutation) to the building... Read More
Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor receptor 2 (HER2) mutations.
Advanced NSCLC is a group of lung cancers that have spread to nearby tissues or to other parts of the body or that are unlikely to be cured or controlled with currently available treatments. HER2 is a protein that helps cells to grow and divide. A damage (also called mutation) to the building plans (genes) for this protein in cancer cells leads to a production of abnormal HER2 and therefore abnormal cell growth and division.
The study treatment, BAY 2927088, is expected to block the mutated HER2 protein which may stop the spread of NSCLC.
The main purpose of this study is to learn how well BAY 2927088 works and how safe it is compared with standard treatment, in participants who have advanced NSCLC with specific genetic changes called HER2 mutations.
The study participants will receive one of the study treatments:
* BAY 2927088 twice every day as a tablet by mouth, or
* Standard treatment in cycles of 21 days via infusion ("drip") into the vein. The treatment will continue for as long as participants benefit from it without any severe side effects or until they or their doctor decide to stop the treatment.
During the study, the doctors and their study team will:
* take imaging scans, including CT, PET, MRI, and X-rays, of different parts of the body to study the spread of cancer
* check the overall health of the participants by performing tests such as blood and urine tests, and checking
* heart health using an electrocardiogram (ECG)
* perform pregnancy tests for women
* ask the participants questions about how they are feeling and what adverse events they are having.
An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatment. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Patty & George Hoag Cancer Center, Newport Beach, California +278 locations
Patty & George Hoag Cancer Center, Newport Beach, California
UC San Diego Health - Moores Cancer Center, San Diego, California
UCSF Bakar Precision Cancer Medicine Building - Thoracic Surgery and Oncology, San Francisco, California
UCLA Health Santa Monica Cancer Care, Santa Monica, California
The Oncology Institute of Hope and Innovation - Fort Lauderdale 17th Street, Fort Lauderdale, Florida
Memorial Cancer Institute at Miramar, Miramar, Florida
AdventHealth Cancer Institute, Orlando, Florida
Moffitt Cancer Center - Magnolia Campus, Tampa, Florida
Moffitt Cancer Center, Tampa, Florida
Piedmont Cancer Institute - Atlanta, Atlanta, Georgia
John B. Amos Cancer Center, Columbus, Georgia
University of Illinois Hospital - Outpatient Cancer Care Center, Chicago, Illinois
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology, Chicago, Illinois
UM Greenebaum Comprehensive Cancer Center, Baltimore, Maryland
UMass Memorial Medical Center - University Campus - Oncology, Worcester, Massachusetts
Profound Research -OMG - TriAtria Cancer Center, Farmington Hills, Michigan
Profound Research - OMG - Royal Oak Cancer Center, Royal Oak, Michigan
University of Minnesota Medical Center, Minneapolis, Minnesota
R.J. Zuckerberg Cancer Center, New Hyde Park, New York
UC Medical Center - Oncology, Cincinnati, Ohio
Providence Cancer Institute - Franz Clinic, Portland, Oregon
Providence Oncology and Hematology Care Clinic Westside, Portland, Oregon
Allegheny General Hospital, Pittsburgh, Pennsylvania
UT Southwestern, Dallas, Texas
University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston, Texas
Virginia Commonwealth University, Richmond, Virginia
Fundación Cenit para la Investigación en Neurociencias, Caba, Ciudad Auton. De Buenos Aires
Hospital Italiano de Buenos Aires, Buenos Aires, Not set
Centro de Educacion Medica e Investigaciones Clinicas "Norberto Quirno" (CEMIC), Buenos Aires, Not set
Centro Médico Privado CEMAIC, Córdoba, Not set
Instituto Argentino de Diagnostico y Tratamiento (IADT), TBC, Not set
Centro de Investigaciones Clínicas, Clínica Viedma, Viedma, Not set
Blacktown Cancer & Haematology Centre, Blacktown, New South Wales
Concord Repatriation General Hospital - Medical Oncology Clinical Trials Unit, Concord, New South Wales
Calvary Mater Hospital Newcastle, Waratah, New South Wales
University of the Sunshine Coast, Buderim, Not set
The Canberra Hospital (TCH) - Canberra Region Cancer Centre (CRCC), Garran, Not set
Austin Hospital - Olivia Newton John Cancer Research Institute, Heidelberg, Not set
Uniklinikum Salzburg, Universitätsklinik für Innere Medizin III, Salzburg, Not set
Uniklinikum Salzburg, Universitätsklinik für Pneumologie/ Lungenheilkunde, Salzburg, Not set
Medizinische Universität Wien Universitätsklinik f. Innere Medizin I Klinische Abteilung für Onkologie, Wien, Not set
Klinik Floridsdorf, Pneumo-onkologische Ambulanz und Tagesklinik, Wien, Not set
UZ Leuven Gasthuisberg - Pneumology Department, Leuven, Vlaams-Brabant
AZ Delta | Clinical Trial Center - Pneumology, Roeselare, West-Flanders
Antwerp University Hospital | Oncology Department, Antwerpen, Not set
Rede DoR Recife - PE, Recife, Pernambuco
Liga Norte Riograndense Contra o Cancer | Centro de Pesquisa Clínica, Natal, Rio Grande Do Norte
Irmandade Santa Casa de Misericordia de Porto Alegre | Oncology, Porto Alegre, Rio Grande Do Sul
Centro de Pesquisa da Clínica de Oncologia Reichow, Blumenau, Santa Catarina
Fundacao Pio XII - Hospital de Cancer de Barretos, Barretos, Sao Paulo
Hospital de Base | Integrated Research Center, São José do Rio Preto, Sao Paulo
NAIC - Instituto do Cancer, Bauru, Not set
Hospital Sirio-Libanes (HSL) - Centro de Oncologia - Brasilia, Brasilia, Not set
Pronutrir Fortaleza - CE, Fortaleza, Not set
Hospital Sirio Libanes, Sao Paulo, Not set
A Beneficencia Portuguesa de Sao Paulo - Hospital BP Mirante, Sao Paulo, Not set
Centro Paulista de Oncologia (CPO) - Sao Paulo - Faria Lima, Sao Paulo, Not set
MHAT Uni Hospital, Panagyurishte, Pazardzhik
MHAT "Heart and brain" Pleven, Pleven, Not set
Complex Oncology Center - Plovdiv EOOD, Plovdiv, Not set
MHAT Park Hospital EOOD, Plovdiv, Not set
Multiprofile Hospital for Active Treatment "Sveta Sofia", Sofia, Not set
MHAT Serdika, Sofia, Not set
Specialized Hospital for Active Treatment of Oncology, Sofia, Not set
University Multiprofile Hospital For Active Treatment Sofiamed OOD, Sofia, Sofia, Not set
MHAT Sveta Marina EAD, Varna, Not set
BC Cancer - Vancouver Site, Vancouver, British Columbia
Brampton Civic Hospital - Oncology, Brampton, Ontario
Princess Margaret Cancer Centre - University Health Network - Department of Medical Oncology and Hematology, Toronto, Ontario
Jewish General Hospital - Department of Pulmonary Oncology, Montreal, Quebec
Beijing Cancer Hospital - Oncology Department, Beijing, Beijing
Beijing Hospital, Beijing, Beijing
Fujian Cancer Hospital, Fuzhou, Fujian
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Union Hospi, Tongji Med College, Huazhong Univ. Scien&Tech, Wuhan, Hubei
Hubei Cancer Hospital, Wuhan, Hubei
Hunan Cancer Hospital - Oncology Department, Changsha, Hunan
NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School, Nanjing, Jiangsu
Jilin Cancer Hospital, Changchun, Jilin
Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, Shanghai
West China Hospital Sichuan University, Chengdu, Sichuan
Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
Zhejiang University School of Medicine - Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Not set
The People's Liberation Army General Hospital (Beijing 301 Hospital), Beijing, Not set
Beijing chest hospital, Capital Medical University, Beijing, Not set
University of Electronic Science & Technology of China - Sichuan Cancer Hospital & Institute (Sichuan Provincial Tumor Hospital), Chengdu, Not set
Guangzhou Medical University - The First Affiliated Hospital, Guangzhou, Not set
Shandong University - Shandong Cancer Hospital, Jinan, Not set
LinYi Cancer Hospital (Linyi Tumor Hospital), Linyi, Not set
Jiangsu Provincial People's Hospital - The First Affiliated Hospital of Nanjing Medical University, Nanjing, Not set
Guangxi Medical University (GXMU) - Affiliated Tumor Hospital, Nanning, Not set
Zhongshan Hospital, Fudan University - Oncology Department, Shanghai, Not set
Xiamen University - The First Affiliated Hospital, Xiamen, Not set
Krajská nemocnice T. Bati - Pneumoonkologická a klinická onkologie, Zlin, Zlinsky Kraj
Masarykova Univerzita - Masarykuv Onkologicky Ustav (MOU) - Klinika Komplexni Onkologicke Pece (KKOP), Brno, Not set
Nemocnice AGEL Nový Jicín a.s. - Oddelení radioterapie a onkologie, Nový Jicín, Not set
Fakultní Nemocnice Olomouc - Klinika plicních nemocí a tuberkulózy, Olomouc, Not set
Nemocnice AGEL Ostrava-Vítkovice a. s. - Plicní oddelení, Ostrava - Vítkovice, Not set
Aalborg University hospital - oncology department, Aalborg, Not set
Aarhus Universitetshospital, Aarhus N, Not set
Rigshospitalet - Kræftbehandling, Copenhagen OE, Not set
Regionshospitalet Gødstrup - Medicinsk afdeling, Herning, Not set
Odense University Hospital - Oncology Department, Odense C, Not set
Docrates Mehiläinen Syöpäsairaala, Helsinki, Not set
Turun yliopistollinen keskussairaala, Turku, Not set
Institut Bergonie - Unicancer Nouvelle Aquitaine, Bordeaux, Not set
Hopital La Cavale Blanche - CHU de Brest - institut de cancerologie et d'imagerie, Brest, Not set
Centre Hospitalier Intercommunal Creteil - Service de pneumologie, Créteil, Not set
Centre Hospitalier Michallon Grenoble - Service pneumologie, La Tronche, Not set
Institut Coeur Poumon CHRU Lille - Pole Cardio-vasculaire et pulmonaire, Lille, Not set
Centre Hospitalier Universitaire de Limoges - unite oncologie thoracique, Limoges, Not set
CHU Montpellier - Hopital Arnaud de Villeneuve - Service oncologie thoracique, Montpellier, Not set
hopital Emile Muller - Service Pneumologie, Mulhouse, Not set
Hopital Nord Laennec - Oncologie medicale thoracique et digestive, Nantes, Not set
Centre Antoine Lacassagne - Departement Oncologie, Nice, Not set
hopital cochin APHP - service de pneumologie, Paris, Not set
Institut Curie - Paris - Oncologie medicale, Paris, Not set
hopital Lyon sud HCL - Pneumologie aigue specialisee et cancerologie thoracique, Pierre Bénite, Not set
CHU de Rouen - Hopital Charles Nicolle - Service de Pneumologie, Rouen, Not set
Institut de Cancerologie Ouest - Saint-Herblain, Saint-Herblain, Not set
Hopital Foch - Oncologie digestive et thoracique, Suresnes, Not set
Gustave Roussy - Departement Oncologie-Radiotherapie, Villejuif, Not set
Universitaetsklinikum Giessen und Marburg - Medizinische Klinik IV Organonkologie, Giessen, Hessen
Kliniken der Stadt Köln gGmbH - Krankenhaus Merheim - Lungenklinik, Köln, Nordrhein-Westfalen
Universitaetsklinikum Essen - Innere Klinik (Tumorforschung), Essen, North Rhine-Westphalia
Charité Universitätsmedizin Berlin CBF - Med. Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Berlin, Not set
Universitätsklinikum Frankfurt - Medizinische Klinik II, Hämatologie und Onkologie, Frankfurt, Not set
Lungenklinik Hemer, Thorakale Onkologie und onkologische Palliativmedizin, Hemer, Not set
Klinikum Nürnberg - Klinik für Innere Medizin 3, Schwerpunkt Pneumologie (Lungenheilkunde), Nürnberg, Not set
Robert Bosch Krankenhaus - Haematologie, Onkologie und Palliativmedizin, Stuttgart, Not set
?enry Durant Hospital Center-4th Oncology Department and Clinical Trials Unit, Athens, Not set
University of Athens Medical School-Sotiria General Hospital - 3rd Dept of Medicine & Medical Oncology, Athens, Not set
General Hospital of Athens "Alexandra''-Plasma Cell Dyscrasias,Department of Clinical Therapeutics,School of Medicine,NKUA, Athens, Not set
University General Hospital ATTIKON, Department of Internal Medicine IV, Chaidari, Not set
University General Hospital of Athens "ATTIKON", Chaidari, Not set
University General Hospital of Larissa, Larissa, Not set
Metropolitan Hospital- 4th Oncology Clinic, Piraeus, Not set
Bioclinic Thessaloniki, Thessaloniki, Not set
PAPANIKOLAOU General Hospital of Thessaloniki, Thessaloniki, Not set
Prince of Wales Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Queen Elizabeth Hospital Hong Kong, Hong Kong, Not set
Hong Kong United Oncology Centre, Kowloon, Not set
Budapesti Uzsoki Utcai Korhaz - Tüdogyógyászati Osztály, Budapest, Not set
Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabanya, Not set
Assuta Ashdod Public Hospital (R.A), Ashdod, Not set
Soroka Medical Center- Legacy Heritage Cancer Center, Be'er Sheva, Not set
Shaare Zedek Medical Center (SZMC), Jerusalem, Not set
Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set
AORN San Giuseppe Moscati Avellino - U.O.C. Oncologia Medica, Avellino, Campania
Azienda Ospedaliero-Universitaria Di Bologna IRCCS_Policlinico Sant'Orsola - UOC Oncologia Medica, Bologna, Emilia-Romagna
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l. - GDP Toracica, Meldola, Emilia-Romagna
Centro di Riferimento Oncologico di Aviano - Oncologia Medica e dei Tumori Immuno-Correlati, Aviano, Friuli-Venezia Giulia
I.F.O. Istituti Fisioterapici Ospitalieri_Ospedale Regina Elena -- Oncologia Medica 2, Roma, Lazio
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOSD Oncologia Toraco-Polmonare, Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori - S. C. Oncologia Medica 1, Milano, Lombardia
Istituto Europeo di Oncologia s.r.l - Oncologia Toracica, Milano, Lombardia
Humanitas Mirasole S.p.A. - Oncologia Medica ed Ematologia, Rozzano, Lombardia
Azienda Ospedaliero-Universitaria San Luigi Gonzaga - Oncologia Medica, Orbassano, Piemonte
Istituto Oncologico Veneto_Padova - UOC Oncologia 2, Padova, Veneto
Careggi University Hospital - Oncologia Clinica, Firenze, Not set
Careggi University Hospital - Oncologia Clinica, Firenze, Not set
Ospedale Vito Fazzi Lecce - Oncologia, Lecce, Not set
Ospedale San Raffaele s.r.l. - Oncologia Medica, Milano, Not set
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello - Oncologia Medica, Palermo, Not set
ASST Sette Laghi_Ospedale Macchi - Oncologia, Varese, Not set
Centro Ricerche Cliniche Di Verona S.r.l. - Oncologia, Verona, Not set
National Hospital Organization Nagoya Medical Center, Nagoya, Aichi
National Cancer Center Hospital East, Kashiwa, Chiba
Hokkaido University Hospital, Sapporo, Hokkaido
National Hospital Organization Himeji Medical Center, Himeji, Hyogo
Kobe University Hospital, Kobe, Hyogo
Kitasato University Hospital, Sagamihara, Kanagawa
Sendai Kousei Hospital, Sendai, Miyagi
Kansai Medical University Hospital, Hirakata, Osaka
Kindai University Hospital, Osakasayama, Osaka
Saitama Cancer Center, Kitaadachi-gun, Saitama
Nippon Medical School - Nippon Medical School Hospital - Cancer Center, Bunkyo-ku, Tokyo
Tottori University Hospital, Yonago, Tottori
National Hospital Organization-Yamaguchi-Ube Medical Center (Sanyo Hospital), Ube, Yamaguchi
National Hospital Organization Kyushu Medical Center, Fukuoka, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Osaka International Cancer Institute, Osaka, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbugdo
Gyeongsang National University Hospital, Jinju-si, Gyeongsangnam-do
Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnamdo
Severance Hospital, Yonsei University Health System - Oncology Department, Seoul, Seoul Teugbyeolsi
Seoul National University Hospital, Seoul, Seoul Teugbyeolsi
Chonnam National University Hwasun Hospital, Hwasun Gun, Not set
Samsung Medical Center - Oncology Department, Seoul, Not set
Beacon Hospital, Petaling Jaya, Selangor
Columbia Asia Hospital Bukit Rimau, Shah Alam, Selangor
Sunway Medical Centre, Subang Jaya, Selangor
University Hospital Kebangsaan Malaysia, Cheras, Not set
Gleneagles Penang Medical Center, George Town,, Not set
University Malaya Medical Centre, Kuala Lumpur, Not set
Sunway Medical Centre Penang, Perai, Not set
Instituto Nacional de Cancerología, Mexico, Distrito Federal
Oncare Viaducto Nápoles, Cdmx, Not set
Oncología Integral Satélite, Naucalpan, Not set
Hospital Universitrio Dr. José Eleuterio González. Servicio de Oncologia, Nuevo León, Not set
Clinica Integral Internacional de Oncologia S. de R.L. de C.V., Puebla, Not set
ONCARE Treatment Center, San Pedro Garza García, Not set
Nederlands Kanker Instituut, Amsterdam, Not set
Radboud University Medical Center | Afdeling Interne Geneeskunde, Nijmegen, Not set
Narodowy Instytut Onkologii-im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy - Nowotworow Pluca i Klatki Piersiowej, Warsaw, Mazowieckie
Narodowy Instytut Onkologii-im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy - Nowotworow Pluca i Klatki Piersiowej, Warsaw, Mazowieckie
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok, Not set
Swietokrzyskie Centrum Onkologii, Kielce, Not set
Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego w Lodzi, Lodz, Not set
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy w Otwocku, Otwock, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznan, Not set
Dolnoslaskie Centrum Onkologii, Pulmonologii i Hematologii, Wroclaw, Not set
Hospital Pedro Hispano | Clinical Research Center, Matosinhos, Porto
Unidade Local Saúde Coimbra, E.P.E, Coimbra, Not set
Fundacao Champalimaud | Centro Clinico Champalimaud - Unidade Investigacao Clinica, Lisboa, Not set
CHULN - Hospital Pulido Valente, Lisboa, Not set
IPO Porto, Porto, Not set
Radiotherapy Center Cluj SRL, Flore?ti, Comuna Floresti
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu (IOB); Oncologie Medicala II, Bucuresti, Not set
Spitalul Clinic Coltea, Bucuresti, Not set
CardioMed S.R.L., Cluj-Napoca, Not set
Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca, Not set
Sc Oncolab Srl, Craiova, Not set
Centrul de Oncologie Sfantul Nectarie, Craiova, Not set
S.C Ovidius Clinical Hospital SRL - Oncology Department, Ovidiu, Not set
Oncocenter, Timisoara, Not set
Raffles Cancer Centre, Singapore, Not set
OncoCare Cancer Centre | Gleneagles Medical Centre, Singapore, Not set
Tan Tock Seng Hospital, Singapore, Not set
Curie Oncology | Farrer, Singapore, Not set
POKO Poprad s.r.o., Poprad, Not set
Fakultna nemocnica Trnava, Trnava, Not set
Hospital Universitario Puerta De Hierro De Majadahonda - Oncologia, Majadahonda, Madrid
Complejo Hospitalario Universitario A Coruna (CHUAC), A Coruna, Not set
Institut Catala d'Oncologia (ICO) - Hospital Universitari Germans Trias i Pujol (HUGTP) Location, Badalona, Not set
Hospital Quiron Dexeus - Oncologia, Barcelona, Not set
Ciutat Sanitaria i Universitaria de la Vall d'Hebron, Barcelona, Not set
Hospital Clinic de Barcelona (Hospital Clinic i Provincial), Barcelona, Not set
Hospital General Universitario Gregorio Maranon | Oncologia, Madrid, Not set
Hospital Universitario Ramon Y Cajal - Oncologia, Madrid, Not set
Hospital Universitario Fundacion Jimenez Diaz- Oncology Service, Madrid, Not set
Hospital Universitario De Navarra - Oncologia, Pamplona, Not set
Fundacion Instituto Valenciano de Oncologia (IVO, Valencia, Not set
Hospital Universitario Y Politecnico La Fe - Oncologia, Valencia, Not set
Skåne University Hospital, Lund, Not set
Norrland University Hospital - Cancercentrum, Umeå, Not set
Kantonsspital Baden, Baden, Aargau
HFR Freiburg - Kantonsspital, Fribourg, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Kaohsiung
National Cheng Kung University Hospital, Tainan, TNN
Chung Shan Medical University Hospital, Taichung, Not set
Taichung Veterans General Hospital, Taichung, Not set
Chi-Mei Medical Center, Liouyine, Tainan, Not set
National Taiwan University Hospital (NTUH) - Cancer Research Center, Taipei, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Ankara Bilkent Sehir Hastanesi, Bilkent Ankara, Not set
Marmara University Hospital, Istanbul, Not set
Ege Universitesi Tip Fakultesi, Izmir, Not set
Istanbul Medeniyet Üniversitesi Göztepe Süleyman Yalçin Sehir Hastanesi, Kadikoy, Not set
I.A.Ü. VM Medical Park Florya Hastanesi, Kucukcekmece, Not set
Sakarya Universitesi Egitim ve Arastirma Hastanesi, Sakarya, Not set
Ankara Etlik Sehir Hastanesi, Yenimahalle, Not set
Adana Sehir Egitim ve Arastirma Hastanesi, Yuregir, Not set
LLC "RDP Ukraine" - Medical Department, Dnipro, Not set
Private Enterprise Private Production Company "Acinus", Treatment and Diagnostic Center, Kropyvnytskyi, Not set
Kyiv City Clinical Oncology Center - Department of Chemotherapy #1, Kyiv, Not set
Limited Liability Company "MedOffice Group Medical Center", Kyiv, Not set
Medical Center LLC "Verum Expert Clinic", Kyiv, Not set
Volyn Regional Oncology Center, Lutsk, Not set
Municipal Enterprise 'Rivne Regional Antitumor Center" of the Rivne Regional Council", Rivne, Not set
MNCE "Uzhhorod City Multidisciplinary Clinical Hospital" -Oncology Department, Uzhhorod, Not set
Torbay Hospital, Torquay, Devon
Belfast City Hospital, Belfast, North Ireland
Royal Surrey County Hospital, Guildford, Surrey
Velindre University NHS Trust | Velindre Cancer Centre - Clinical Trials Unit, Cardiff, Not set
Conditions: Advanced Non-small Cell Lung Cancer, HER2 Mutation
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Recruiting
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed by pembrolizumab with or without maintenance sacituzumab tirumotecan (sac-TMT; MK-2870) in first-line treatment of metastatic squamous non-small cell lung cancer. It is hypothesized that pembrolizumab with maintenance sacituzumab tirumotecan is superior to pembrolizumab without sacituzumab tirumotecan maintenance with respect to overall survival (OS).
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed by pembrolizumab with or without maintenance sacituzumab tirumotecan (sac-TMT; MK-2870) in first-line treatment of metastatic squamous non-small cell lung cancer. It is hypothesized that pembrolizumab with maintenance sacituzumab tirumotecan is superior to pembrolizumab without sacituzumab tirumotecan maintenance with respect to overall survival (OS). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: CARTI Cancer Center ( Site 0006), Little Rock, Arkansas +188 locations
CARTI Cancer Center ( Site 0006), Little Rock, Arkansas
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0122), Burbank, California
Exempla Lutheran Medical Center ( Site 0119), Golden, Colorado
Intermountain Health St. Mary's Regional Hospital ( Site 0116), Grand Junction, Colorado
Mid Florida Hematology and Oncology Center ( Site 0109), Orange City, Florida
Centricity Research Columbus Cancer Center ( Site 0111), Columbus, Georgia
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0001), Marietta, Georgia
University of Chicago Medical Center ( Site 0145), Chicago, Illinois
Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0146), Minneapolis, Minnesota
New Mexico Oncology Hematology Consultants Ltd. ( Site 0123), Albuquerque, New Mexico
Thomas Jefferson University - Clinical Research Institute ( Site 0147), Philadelphia, Pennsylvania
Oncology Consultants P.A. ( Site 0124), Houston, Texas
Mays Cancer Center ( Site 0132), San Antonio, Texas
Instituto Alexander Fleming ( Site 0203), Ciudad Autónoma de Buenos Aires, Buenos Aires
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0200), Mar del Plata, Buenos Aires
Instituto Médico Río Cuarto ( Site 0204), Rio Cuarto., Cordoba
Fundacion Intecnus ( Site 0205), San Carlos de Bariloche, Rio Negro
Sanatorio Parque ( Site 0201), Rosario, Santa Fe
Hospital Aleman-Oncology ( Site 0202), Buenos Aires, Not set
Ordensklinikum Linz GmbH Elisabethinen-Department of Pneumology ( Site 0720), Linz, Oberosterreich
Klinik Hietzing ( Site 0740), Wien, Not set
Standort Penzing der Klinik Ottakring-Abteilung für Atemwegs-und Lungenkrankheiten ( Site 0730), Wien, Not set
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 0710), Wien, Not set
Hospital de Câncer de Recife ( Site 0312), Recife, Pernambuco
Oncoclínica Oncologistas Associados ( Site 0309), Terezina, Piaui
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0311), Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceição ( Site 0300), Porto Alegre, Rio Grande Do Sul
Instituto de Oncologia Saint Gallen ( Site 0304), Santa Cruz do Sul, Rio Grande Do Sul
Hospital de Base de São José do Rio Preto ( Site 0310), São José do Rio Preto, Sao Paulo
Hospital Paulistano ( Site 0307), Sao Paulo, Not set
Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 0100), Kingston, Ontario
Waterloo Regional Health Network (WRHN) ( Site 0153), Kitchener, Ontario
St. Marys Hospital Center ( Site 0105), Montreal, Quebec
McGill University Health Centre ( Site 0103), Montréal, Quebec
Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0106), Trois-Rivières, Quebec
Centro de Investigación del Maule ( Site 0419), Talca, Maule
FALP ( Site 0409), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0402), Santiago, Region M. De Santiago
Bradfordhill-Clinical Area ( Site 0407), Santiago, Region M. De Santiago
ONCOCENTRO APYS-ACEREY ( Site 0400), Viña del Mar, Valparaiso
Bradford Hill Norte ( Site 0420), Antofagasta, Not set
Beijing Cancer Hospital ( Site 2411), Beijing, Beijing
Beijing Cancer hospital-intrathoratic deparmtment II ( Site 2410), Beijing, Beijing
Peking Union Medical College Hospital ( Site 2412), Beijing, Beijing
Army Medical Center of People's Liberation Army-respiratory ( Site 2426), Chongqing, Chongqing
Fujian Provincial Cancer Hospital ( Site 2419), Fuzhou, Fujian
The First Affiliated hospital of Xiamen University-oncology ( Site 2420), Xiamen, Fujian
The First Affiliated Hospital of Guangzhou Medical University ( Site 2417), Guangzhou, Guangdong
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 2416), Guangzhou, Guangdong
Harbin Medical University Cancer Hospital-oncology of department ( Site 2415), Harbin, Heilongjiang
Henan Cancer Hospital-Pneumology department ( Site 2423), Zhengzhou, Henan
Tongji Hospital Tongji Medical,Science & Technology ( Site 2424), Wuhan, Hubei
The Second Xiangya Hospital of Central South University-Oncology ( Site 2418), Changsha, Hunan
First Huai'an Hospital Affiliated to Nanjing Medical University ( Site 2402), Huai'an, Jiangsu
Northern Jiangsu People's Hospital-General Surgery Department ( Site 2403), Yangzhou, Jiangsu
The Second Affiliated Hospital of Nanchang University-Oncology Department ( Site 2405), Nanchang, Jiangxi
The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 2404), Nanchang, Jiangxi
Jilin Province Tumor Hospital-GCP office ( Site 2413), Changchun, Jilin
The First Hospital of Jilin University-Oncology ( Site 2414), Changchun, Jilin
Shanghai East Hospital ( Site 2428), Shanghai, Shanghai
Shanghai Pulmonary Hospital ( Site 2427), Shanghai, Shanghai
West China Hospital, Sichuan University ( Site 2422), Cheng Du, Sichuan
Sichuan Cancer hospital. ( Site 2421), Chengdu, Sichuan
The Affiliated Cancer Hospital of Xinjiang Medical University ( Site 2425), Urumqi, Xinjiang
The first Affiliated Hospital, Zhejiang University School of Medicine-Respiratory Department ( Site 2406), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine-Medical Oncology ( Site 2407), Hangzhou, Zhejiang
Zhejiang Cancer Hospital-Breast Oncology ( Site 2408), Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province ( Site 2430), Taizhou, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University-Respiratory department ( Site 2409), Wenzhou, Zhejiang
Centro Cancerológico del Caribe (CECAC) ( Site 0509), Barranquilla, Atlantico
Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0501), Valledupar, Cesar
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0500), Bogota, Distrito Capital De Bogota
Oncologos del Occidente ( Site 0504), Pereira., Risaralda
Fundación Valle del Lili-Oncology CIC ( Site 0505), Cali, Valle Del Cauca
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0800), Brno, Brno-mesto
Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 0803), Ostrava-Vitkovice, Ostrava Mesto
Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 0802), Olomouc, Not set
Clinique Clairval ( Site 0904), Marseille, Bouches-du-Rhone
Hôpital Robert Schuman ( Site 0907), Vantoux, Lorraine
Institut de Cancérologie de l'Ouest ( Site 0908), ANGERS cedex 02, Maine-et-Loire
Sainte Catherine Institut du Cancer Avignon Provence ( Site 0902), Avignon, Vaucluse
CHD Vendee ( Site 0901), La Roche-sur-Yon, Vendee
Hôpital Saint-Louis ( Site 0906), Paris, Not set
GEFOS Gesellschaft f. onkologische Studien ( Site 1005), Dortmund, Nordrhein-Westfalen
Universitätsklinikum Schleswig-Holstein-Pneumologie ( Site 1000), Luebeck, Schleswig-Holstein
SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1006), Gera, Thuringen
Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 1003), Berlin, Not set
Bacs-Kiskun Varmegyei Oktatokorhaz ( Site 1100), Kecskemét, Bacs-Kiskun
Petz Aladar Egyetemi Oktato Korhaz ( Site 1101), Gyor, Gyor-Moson-Sopron
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 1103), Szolnok, Jasz-Nagykun-Szolnok
Reformatus Pulmonologiai Centrum ( Site 1102), Torokbalint, Pest
Zala Megyei Szent Rafael Kórház ( Site 1110), Zalaegerszeg, Zala
Országos Korányi Pulmonológiai Intézet ( Site 1104), Budapest, Not set
St. James's Hospital ( Site 1200), Dublin, Not set
Rambam Health Care Campus-Oncology Division ( Site 1302), Haifa, Not set
Shaare Zedek Medical Center ( Site 1300), Jerusalem, Not set
Rabin Medical Center ( Site 1303), Petah Tikva, Not set
Sheba Medical Center ( Site 1301), Ramat Gan, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia clinica sperimentale Toraco-Polmonare ( Site 1401), Napoli, Campania
Azienda Ospedaliera S. Giovanni Addolorata-Oncologia Medica ( Site 1409), Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1404), Milan, Lombardia
Fondazione IRCCS San Gerardo dei Tintori-Oncologia ( Site 1412), Monza, Lombardia
Istituto Clinico Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1408), Rozzano, Milano
Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 1402), Rome, Roma
Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 1414), Brescia, Not set
Ospedale San Martino ( Site 1407), Genova, Not set
Fondazione IRCCS Policlinico San Matteo-Oncology ( Site 1410), Pavia, Not set
Ospedale di Circolo e Fondazione Macchi Varese-Oncology ( Site 1413), Varese, Not set
Aichi Cancer Center ( Site 2502), Nagoya, Aichi
Nagoya University Hospital ( Site 2519), Nagoya, Aichi
Fujita Health University Hospital ( Site 2515), Toyoake, Aichi
Hirosaki University Hospital ( Site 2514), Hirosaki, Aomori
Ehime University Hospital ( Site 2511), Toon, Ehime
Gunma Prefectural Cancer Center ( Site 2510), Ota, Gunma
Takarazuka City Hospital ( Site 2508), Takarazuka, Hyogo
Kanazawa University Hospital ( Site 2513), Kanazawa, Ishikawa
St. Marianna University Hospital ( Site 2521), Kawasaki, Kanagawa
Kanagawa Cardiovascular and Respiratory Center ( Site 2518), Yokohama, Kanagawa
Kanagawa Cancer Center ( Site 2504), Yokohama, Kanagawa
Matsusaka Municipal Hospital ( Site 2522), Matsusaka, Mie
Sendai Kousei Hospital ( Site 2507), Sendai, Miyagi
Kansai Medical University Hospital ( Site 2503), Hirakata, Osaka
Saitama Prefectural Cancer Center ( Site 2512), Kitaadachi-gun, Saitama
Cancer Institute Hospital of JFCR ( Site 2500), Koto, Tokyo
Toho University Omori Medical Center ( Site 2520), Ota, Tokyo
National Center for Global Health and Medicine ( Site 2516), Shinjuku, Tokyo
National Hospital Organization Yamaguchi Ube Medical Center ( Site 2523), Ube, Yamaguchi
Chiba University Hospital ( Site 2517), Chiba, Not set
National Hospital Organization Kyushu Medical Center ( Site 2509), Fukuoka, Not set
Niigata Cancer Center Hospital ( Site 2505), Niigata, Not set
Osaka International Cancer Institute ( Site 2506), Osaka, Not set
The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 2106), Bupyeong-gu, Incheon
Pusan National University Yangsan Hospital ( Site 2104), Yangsan-si, Kyongsangnam-do
Pusan National University Hospital ( Site 2100), Busan, Pusan-Kwangyokshi
Kyungpook National University Chilgok Hospital-Pulmonology ( Site 2102), Deagu, Taegu-Kwangyokshi
Chungnam national university hospital-Department of Internal Medicine ( Site 2107), Daejeon, Taejon-Kwangyokshi
Kyung Hee University Hospital ( Site 2101), Seoul, Not set
Asan Medical Center ( Site 2105), Seoul, Not set
Korea University Guro Hospital-Internal Medicine ( Site 2103), Seoul, Not set
Clínicas AUNA Sede Chiclayo ( Site 0604), Chiclayo, Lambayeque
Oncosalud-Clinical Research ( Site 0600), Lima, Not set
Hospital Militar Central Coronel Luis Arias Schereiber ( Site 0602), Lima, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 1510), Poznań, Dolnoslaskie
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1503), Bydgoszcz, Kujawsko-pomorskie
Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 1513), Grudziadz, Kujawsko-pomorskie
Szpital Specjalistyczny im. Henryka Klimontowicza ( Site 1507), Gorlice, Malopolskie
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 1515), Kraków, Malopolskie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 1500), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1501), Przemysl, Podkarpackie
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1517), Koszalin, Zachodniopomorskie
Centrul Medical Medicover Victoria ( Site 2000), Bucharest, Bucuresti
Cardiomed SRL Cluj-Napoca ( Site 2002), Cluj-Napoca, Cluj
SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2001), Florești, Cluj
Centrul de Oncologie Sfantul Nectarie-Medical ( Site 2004), Craiova, Dolj
Cabinet Medical Oncomed ( Site 2005), Timisoara, Timis
SC ONCO CARD SRL ( Site 2007), Brasov, Not set
Clinica Polisano ( Site 2008), Sibiu, Not set
CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 1703), Santiago de Compostela, Galicia
Hospital Insular de Gran Canaria-Oncology ( Site 1701), Las Palmas de Gran Canaria, Las Palmas
Hospital Quirón Málaga ( Site 1704), Málaga, Malaga
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1700), Barcelona, Not set
Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 1702), Madrid, Not set
Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 1705), Sevilla, Not set
National Taiwan University Cancer Center (NTUCC) ( Site 2209), Taipei City, Taipei
Taoyuan General Hospital ( Site 2203), Taoyuan City, Taoyuan
Chang Gung Memorial Hospital at Kaohsiung ( Site 2207), Kaohsiung, Not set
Taichung Veterans General Hospital ( Site 2204), Taichung, Not set
National Cheng Kung University Hospital ( Site 2205), Tainan, Not set
National Taiwan University Hospital-Oncology ( Site 2208), Taipei, Not set
Mackay Memorial Hospital-Chest Medicine ( Site 2201), Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch-Clinic of Chest Medicine ( Site 2202), Taoyuan, Not set
Prapokklao Hospital ( Site 2306), Mueang, Chanthaburi
Faculty of Medicine - Khon Kaen University ( Site 2305), Muang, Khon Kaen
Faculty of Medicine Siriraj Hospital ( Site 2301), Bangkok, Krung Thep Maha Nakhon
Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 2300), Dusit, Krung Thep Maha Nakhon
Lampang Cancer Hospital ( Site 2304), Mueang Lampang, Lampang
Songklanagarind hospital ( Site 2303), HatYai, Songkhla
Maharaj Nakorn Chiang Mai Hospital ( Site 2302), Chiang Mai, Not set
Medipol Mega Universite Hastanesi-oncology ( Site 1811), Stanbul, Istanbul
Hacettepe Universite Hastaneleri-oncology hospital ( Site 1801), Ankara, Not set
Gazi Universitesi-Oncology ( Site 1804), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1800), Ankara, Not set
Memorial Kayseri Hastanesi ( Site 1805), Kayseri, Not set
Mersin Sehir Eğitim ve Araştırma Hastanesi-Oncology ( Site 1808), Mersin, Not set
Samsun Medical Park Hastanesi-medical oncology ( Site 1806), Samsun, Not set
Burjeel Medical City ( Site 2600), Abu Dhabi, Abu Zaby
Torbay Hospital ( Site 1906), Torquay, Devon
St Bartholomew's Hospital ( Site 1901), London, London, City Of
City Hospital, Nottingham University Hospitals NHS Trust-NCCTT ( Site 1911), Nottingham, Nottinghamshire
Conditions: Non-small Cell Lung Cancer, NSCLC
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Recruiting
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates... Read More
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates for anti-PD(L)1 therapy and endocrine therapies. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Local Institution - 0303, Hot Springs, Arkansas +241 locations
Local Institution - 0303, Hot Springs, Arkansas
Local Institution - 0307, Cerritos, California
Local Institution - 0308, Cerritos, California
Local Institution - 0309, Cerritos, California
Local Institution - 0311, Long Beach, California
Local Institution - 0290, Los Angeles, California
Local Institution - 0283, Los Angeles, California
Local Institution - 0328, Whittier, California
Local Institution - 0289, Aurora, Colorado
Local Institution - 0304, Newark, Delaware
Local Institution - 0282, Miami, Florida
Local Institution - 0296, Pembroke Pines, Florida
Local Institution - 0294, Atlanta, Georgia
Local Institution - 0278, Chicago, Illinois
Local Institution - 0280, Chicago, Illinois
Decatur Memorial Hospital, Decatur, Illinois
Local Institution - 0324, O'Fallon, Illinois
Local Institution - 0286, Covington, Louisiana
Local Institution - 0288, Boston, Massachusetts
Local Institution - 0287, Boston, Massachusetts
Local Institution - 0313, Minneapolis, Minnesota
Local Institution - 0284, Kansas City, Missouri
Local Institution - 0312, New York, New York
Local Institution - 0279, New York, New York
Clinical Research Alliance, Westbury, New York
Local Institution - 0285, White Plains, New York
Local Institution - 0276, Durham, North Carolina
Local Institution - 0316, Eugene, Oregon
Local Institution - 0310, Philadelphia, Pennsylvania
Local Institution - 0281, Greenville, South Carolina
Local Institution - 0315, Austin, Texas
Local Institution - 0314, Houston, Texas
Local Institution - 0305, Tyler, Texas
Local Institution - 0277, Midlothian, Virginia
Local Institution - 0301, Roanoke, Virginia
Local Institution - 0302, Winchester, Virginia
Local Institution - 0345, Buenas Aires, Buenos Aires
Local Institution - 0011, Ciudad autónoma de Buenos Aires, Buenos Aires
Local Institution - 0214, ABB, Ciudad Autónoma De Buenos Aires
Local Institution - 0143, Cordoba, Córdoba
Local Institution - 0137, Río Cuarto, Córdoba
Local Institution - 0142, Rosario, Santa Fe
Local Institution - 0317, Buenos Aires, Not set
Local Institution - 0346, Buenos Aires, Not set
Local Institution - 0012, Ciudad Autónoma de Buenos Aires, Not set
Local Institution - 0035, Brisbane, Queensland
Local Institution - 0197, Ballarat Central, Victoria
Local Institution - 0031, Heidelberg, Victoria
Local Institution - 0274, Melbourne, Victoria
Local Institution - 0028, Subiaco, Western Australia
Local Institution - 0292, Graz, Steiermark
Local Institution - 0268, Innsbruck, Tirol
Local Institution - 0267, Salzburg, Not set
Local Institution - 0270, St. Polten, Not set
Local Institution - 0269, Wien, Not set
Local Institution - 0187, Manaus, Amazonas
Local Institution - 0147, Fortaleza, Ceará
Local Institution - 0157, Vitória, Espírito Santo
Local Institution - 0199, Porto Alegre, Rio Grande Do Sul
Local Institution - 0164, São José do Rio Preto, São Paulo
Local Institution - 0153, Rio de Janeiro, Not set
Local Institution - 0144, São Paulo, Not set
Local Institution - 0149, São Paulo, Not set
Local Institution - 0218, Kelowna, British Columbia
Local Institution - 0217, Victoria, British Columbia
Local Institution - 0265, Ottawa, Ontario
Local Institution - 0215, Montréal, Quebec
Local Institution - 0219, Montréal, Quebec
Local Institution - 0350, Saint-Jerome, Quebec
Local Institution - 0216, Sherbrooke, Quebec
Local Institution - 0138, Santiago, Región Metropolitana De Santiago
Local Institution - 0021, Santiago, Región Metropolitana De Santiago
Local Institution - 0017, Santiago, Región Metropolitana De Santiago
Local Institution - 0018, Santiago, Región Metropolitana De Santiago
Local Institution - 0016, Viña del Mar, Valparaíso
Local Institution - 0195, Medellín, Antioquia
Local Institution - 0201, Rionegro, Antioquia
Local Institution - 0194, Barranquilla, Atlántico
Local Institution - 0182, Puerto Colombia, Atlántico
Local Institution - 0181, Montería, COR
Local Institution - 0327, Bogota, Cundinamarca
Local Institution - 0183, Cali, Valle Del Cauca
Local Institution - 0349, Medellin, Not set
Local Institution - 0089, Bordeaux, Aquitaine
Local Institution - 0272, Dijon, Côte-d'Or
Local Institution - 0098, Toulouse, Haute-Garonne
Local Institution - 0095, Montpellier, Hérault
Local Institution - 0099, Rennes, Ille-et-Vilaine
Local Institution - 0092, Saint Herblain, Loire-Atlantique
Local Institution - 0091, Reims, Marne
Local Institution - 0097, Villejuif, Paris
Local Institution - 0093, Marseille, Provence-Alpes-Côte-d'Azur
Local Institution - 0096, Clermont-Ferrand, Puy-de-Dôme
Local Institution - 0090, Lyon, Rhône-Alpes
Local Institution - 0094, Lille, Not set
Local Institution - 0088, Paris, Not set
Local Institution - 0320, Esslingen, Baden-Württemberg
Local Institution - 0256, Augsburg, Bayern
Local Institution - 0271, München, Bayern
Local Institution - 0306, Frankfurt, Hessen
Local Institution - 0333, Langen, Hessen
Local Institution - 0257, Hannover, Niedersachsen
Local Institution - 0293, Düsseldorf, Nordrhein-Westfalen
Local Institution - 0263, Essen, Nordrhein-Westfalen
Local Institution - 0254, Leipzig, Sachsen
Local Institution - 0255, Lübeck, Schleswig-Holstein
Local Institution - 0261, Berlin, Not set
Local Institution - 0260, Berlin, Not set
Local Institution - 0259, Bonn, Not set
Local Institution - 0258, Dresden, Not set
Local Institution - 0262, Heidelberg, Not set
Local Institution - 0291, Ulm, Not set
Local Institution - 0042, Athens, Attikí
Local Institution - 0038, Athens, Attikí
Local Institution - 0086, Heraklion, Irakleío
Local Institution - 0043, Athens, Not set
Local Institution - 0266, New Delhi, Delhi
Local Institution - 0206, New Delhi, Delhi
Local Institution - 0131, Mumbai, Maharashtra
Local Institution - 0134, Nagpur, Maharashtra
Local Institution - 0125, Chennai, Tamil Nadu
Local Institution - 0130, Hyderabad, Telangana
Local Institution - 0133, Varanasi, Uttar Pradesh
Local Institution - 0352, New Delhi, Not set
Local Institution - 0186, Petah Tikva, HaMerkaz
Local Institution - 0044, Ramat Gan, HaMerkaz
Local Institution - 0048, Hadera, HaTsafon
Local Institution - 0123, Haifa, HaTsafon
Local Institution - 0047, Jerusalem, Yerushalayim
Local Institution - 0051, Napoli, Campania
Local Institution - 0049, Bologna, Emilia-Romagna
Local Institution - 0057, Aviano, Friuli-Venezia Giulia
Local Institution - 0054, Genova, Liguria
Local Institution - 0053, Pontedera, Pisa
Local Institution - 0055, Prato, Toscana
Local Institution - 0052, Milano, Not set
Local Institution - 0058, Napoli, Not set
Local Institution - 0061, Novara, Not set
Local Institution - 0056, Padova, Not set
Local Institution - 0062, Roma, Not set
Local Institution - 0236, Nagoya, Aichi
Local Institution - 0230, Chiba-shi, Chiba
Local Institution - 0240, Matsuyama, Ehime
Local Institution - 0226, Otashi, Gunma
Local Institution - 0222, Sapporo, Hokkaido
Local Institution - 0232, Kanazawa, Ishikawa
Local Institution - 0234, Isehara, Kanagawa
Local Institution - 0237, Yokohama, Kanagawa
Local Institution - 0246, Tsu, Mie
Local Institution - 0223, Sendai-shi, Miyagi
Local Institution - 0238, Suita, Osaka
Local Institution - 0227, Hidaka, Saitama
Local Institution - 0224, Ina-machi, Saitama
Local Institution - 0231, Bunkyo-ku, Tokyo
Local Institution - 0229, Chuo-ku, Tokyo
Local Institution - 0228, Koto, Tokyo
Local Institution - 0245, Shinagawa, Tokyo
Local Institution - 0233, Shinjuku-ku, Tokyo
Local Institution - 0242, Fukuoka, Not set
Local Institution - 0225, Fukushima, Not set
Local Institution - 0243, Hiroshima, Not set
Local Institution - 0244, Kagoshima, Not set
Local Institution - 0235, Kyoto, Not set
Local Institution - 0241, Okayama, Not set
Local Institution - 0239, Osaka, Not set
Local Institution - 0066, Goyang-si, Kyǒnggi-do
Local Institution - 0067, Seongnam, Kyǒnggi-do
Local Institution - 0068, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0063, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0071, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0064, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0065, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0069, Daegu, Taegu-Kwangyǒkshi
Local Institution - 0264, Tijuana, Baja California
Local Institution - 0177, Mexico City, DIF
Local Institution - 0329, Mexico City, Distrito Federal
Local Institution - 0178, Guadalajara, Jalisco
Local Institution - 0175, Monterrey, Nuevo León
Local Institution - 0176, Monterrey, Nuevo León
Local Institution - 0173, Oaxaca de Juarez, Oaxaca
Local Institution - 0179, Merida, Yucatán
Local Institution - 0174, Chihuahua, Not set
Local Institution - 0074, Biala Podlaska, Lubelskie
Local Institution - 0072, Warszawa, Mazowieckie
Local Institution - 0220, Warszawa, Mazowieckie
Local Institution - 0076, Opole, Opolskie
Local Institution - 0189, Skórzewo, Wielkopolskie
Local Institution - 0221, Łódź, Łódzkie
Local Institution - 0198, Lisbon, Lisboa
Local Institution - 0106, Lisbon, Lisboa
Local Institution - 0109, Lisbon, Lisboa
Local Institution - 0124, Coimbra, Not set
Local Institution - 0141, Lisboa, Not set
Local Institution - 0111, Porto, Not set
Local Institution - 0253, Porto, Not set
Local Institution - 0212, Bistrita, Bistrița-Năsăud
Local Institution - 0213, Bucharest, București
Local Institution - 0079, Florești, Cluj
Local Institution - 0078, Craiova, Dolj
Local Institution - 0084, Ploiești, Prahova
Local Institution - 0211, Dumbravita, Timiș
Local Institution - 0085, Timișoara, Timiș
Local Institution - 0083, București, Not set
Local Institution - 0077, Cluj, Not set
Local Institution - 0081, Iași, Not set
Local Institution - 0080, Iași, Not set
Local Institution - 0351, East London, Eastern Cape
Local Institution - 0342, Parktown, Gauteng
Local Institution - 0336, Pretoria, Gauteng
Local Institution - 0341, Pretoria, Gauteng
Local Institution - 0340, Soweto, Gauteng
Local Institution - 0105, A Coruña, A Coruña [La Coruña]
Local Institution - 0100, Elche, Alicante
Local Institution - 0102, Barcelona, Barcelona [Barcelona]
Local Institution - 0172, Hospitalet, Barcelona [Barcelona]
Local Institution - 0140, Barcelona, Catalunya [Cataluña]
Local Institution - 0139, San Sebastian, Gipuzkoa
Local Institution - 0104, Madrid, Madrid, Comunidad De
Local Institution - 0108, Madrid, Madrid, Comunidad De
Local Institution - 0101, Malaga, Málaga
Local Institution - 0210, Valencia, Valenciana, Comunitat
Local Institution - 0107, Madrid, Not set
Local Institution - 0103, Sevilla, Not set
Local Institution - 0252, Malmö, Skåne Län [se-12]
Local Institution - 0026, Stockholm, Stockholms Län [se-01]
Local Institution - 0025, Uppsala, Uppsala Län [se-03]
Local Institution - 0024, Örebro, Örebro Län [se-18]
Local Institution - 0247, Linköping, Östergötlands Län [se-05]
Local Institution - 0250, st.Gallen, Sankt Gallen
Local Institution - 0249, Lausanne, Vaud
Local Institution - 0251, Zürich, Not set
Local Institution - 0323, Abu Dhabi, Abū Z̧aby
Local Institution - 0318, Abu Dhabi, Abū Z̧aby
Local Institution - 0322, Al Ain, Abū Z̧aby
Local Institution - 0319, Abu Dhabi, Not set
Local Institution - 0208, Truro, England
Local Institution - 0204, London, London, City Of
Local Institution - 0209, London, London, City Of
Local Institution - 0171, Belfast, Not set
Local Institution - 0004, London, Not set
Local Institution - 0001, Manchester, Not set
Local Institution - 0006, Nottingham, Not set
Conditions: Breast Neoplasms
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Recruiting
This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced tumors
This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced tumors Read Less
Gender:
ALL
Ages:
Between 18 years and 130 years
Trial Updated:
07/23/2025
Locations: Research Site, Duarte, California +58 locations
Research Site, Duarte, California
Research Site, Irvine, California
Research Site, La Jolla, California
Research Site, Aurora, Colorado
Research Site, Louisville, Kentucky
Research Site, Boston, Massachusetts
Research Site, Detroit, Michigan
Research Site, Columbus, Ohio
Research Site, Portland, Oregon
Research Site, Providence, Rhode Island
Research Site, Providence, Rhode Island
Research Site, Houston, Texas
Research Site, Fairfax, Virginia
Research Site, Liverpool, Not set
Research Site, Melbourne, Not set
Research Site, Edmonton, Alberta
Research Site, London, Ontario
Research Site, Toronto, Ontario
Research Site, Montréal, Quebec
Research Site, Montréal, Quebec
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Jinan, Not set
Research Site, Xi'an, Not set
Research Site, Zhengzhou, Not set
Research Site, Berlin, Not set
Research Site, Essen, Not set
Research Site, Hannover, Not set
Research Site, Leipzig, Not set
Research Site, Mannheim, Not set
Research Site, Regensburg, Not set
Research Site, Haifa, Not set
Research Site, Ramat Gan, Not set
Research Site, Hidaka-shi, Not set
Research Site, Kashiwa, Not set
Research Site, Koto-ku, Not set
Research Site, Sunto-gun, Not set
Research Site, Tokyo, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Barcelona, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Málaga, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Istanbul, Not set
Research Site, Cambridge, Not set
Research Site, Glasgow, Scotland, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Sutton, Not set
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Recruiting
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/23/2025
Locations: Local Institution - 0347, Birmingham, Alabama +327 locations
Local Institution - 0347, Birmingham, Alabama
Local Institution - 0581, Fullerton, California
Local Institution - 0202, Long Beach, California
Local Institution - 0643, Newport Beach, California
Local Institution - 0666, Orange, California
Local Institution - 0623, Santa Barbara, California
Local Institution - 0442, Denver, Colorado
Local Institution - 0651, Gainesville, Florida
Local Institution - 0621, Palm Bay, Florida
Local Institution - 0377, Tamarac, Florida
Local Institution - 0647, Tampa, Florida
Local Institution - 0392, Fort Eisenhower, Georgia
Local Institution - 0031, Marietta, Georgia
Local Institution - 0665, Arlington Heights, Illinois
Local Institution - 0423, Munster, Indiana
Local Institution - 0366, Edgewood, Kentucky
Local Institution - 0566, Louisville, Kentucky
Local Institution - 0644, Shreveport, Louisiana
Local Institution - 0385, Columbia, Maryland
Local Institution - 0019, Boston, Massachusetts
Local Institution - 0437, Worcester, Massachusetts
Local Institution - 0618, White Plains, New York
Local Institution - 0624, Asheville, North Carolina
Local Institution - 0672, Salisbury, North Carolina
Local Institution - 0620, Columbus, Ohio
Local Institution - 0657, York, Pennsylvania
Local Institution - 0658, Greenville, South Carolina
Local Institution - 0652, Laredo, Texas
Local Institution - 0622, San Antonio, Texas
Local Institution - 0575, Ciudad Autónoma de Buenos Aires, Buenos Aires
IDIM - Instituto de Investigaciones Metabólicas, Ciudad de Buenos Aires, Buenos Aires
Local Institution - 0584, Pilar, Buenos Aires
Hospital Italiano de Buenos Aires, ABB, Ciudad Autónoma De Buenos Aires
Local Institution - 0571, Buenos Aires, Ciudad Autónoma De Buenos Aires
Clinica Adventista Belgrano, Caba, Ciudad Autónoma De Buenos Aires
Sanatorio Plaza, Rosario, Santa Fe
Local Institution - 0126, Canberra, Australian Capital Territory
Tamworth Hospital, North Tamworth, New South Wales
Orange Hospital, Orange, New South Wales
Princess Alexandra Hospital, Brisbane, Queensland
Lyell McEwin Hospital, Elizabeth Vale, South Australia
Frankston Hospital, Frankston, Victoria
Northern Hospital, Melbourne, Victoria
Local Institution - 0160, Traralgon, Victoria
Joondalup Health Campus, Joondalup, Western Australia
Klinikum Wels-Grieskirchen GmbH, Wels, Oberösterreich
Medizinische Universität Graz, Graz, Steiermark
Kepler Universitätsklinikum, Linz, Not set
Medizinische Universität Wien, Wien, Not set
Local Institution - 0673, Wien, Not set
UZ Brussel, Brussels, Bruxelles-Capitale, Région De
Cliniques universitaires Saint-Luc, Brussels, Bruxelles-Capitale, Région De
Local Institution - 0215, Hasselt, Limburg
Local Institution - 0216, Gent, Oost-Vlaanderen
UZ Leuven, Leuven, Vlaams-Brabant
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège, Not set
Local Institution - 0257, Salvador, Bahia
Local Institution - 0242, Vitória, Espírito Santo
Local Institution - 0244, Belo Horizonte, Minas Gerais
Local Institution - 0235, Ijui, Rio Grande Do Sul
Local Institution - 0233, Porto Alegre, Rio Grande Do Sul
Local Institution - 0238, Santa Cruz do Sul, Rio Grande Do Sul
Local Institution - 0243, Porto Velho, Rondonia
Local Institution - 0237, Blumenau, Santa Catarina
Local Institution - 0245, Itajaí, Santa Catarina
Local Institution - 0240, Barretos, São Paulo
Local Institution - 0254, Sao Paulo, São Paulo
Local Institution - 0241, São Carlos, São Paulo
Local Institution - 0239, São José do Rio Preto, São Paulo
Local Institution - 0236, Rio de Janeiro, Not set
Local Institution - 0258, São Paulo, Not set
Local Institution - 0629, Panagyurishte, Pazardzhik
Local Institution - 0628, Sofia, Sofia (stolitsa)
Complex Oncology Center - Ruse EOOD, Ruse, Not set
Local Institution - 0635, Stara Zagora, Not set
Local Institution - 0074, Halifax, Nova Scotia
Local Institution - 0559, Montreal, Quebec
Bradfordhill, Recoleta, Región Metropolitana De Santiago
FALP, Santiago, Región Metropolitana De Santiago
The First Afflilated Hospital of Bengbu Medical College, Bengbu, Anhui
Anhui Provincial Hospital, Hefei, Anhui
Beijing Cancer hospital, Beijing, Beijing
Local Institution - 0491, Beijing, Beijing
Local Institution - 0397, Beijing, Beijing
Chongqing University Cancer Hospital, Chongqing, Chongqing
Local Institution - 0362, Fuzhou Fujian, Fujian
Local Institution - 0383, Xiamen, Fujian
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong
Local Institution - 0625, Guangzhou, Guangdong
Cancer Hospital of Shantou University Medical College, Shantou, Guangdong
Local Institution - 0461, Shenzhen, Guangdong
ShenZhen People's Hospital, Shenzhen, Guangdong
Local Institution - 0464, Nanning, Guangxi
Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Nanyang City Center Hospital, Nanyang, Henan
Local Institution - 0494, Xinxiang, Henan
Tongji Hospital Tongji Medical,Science & Technology, Wuhan, Hubei
Local Institution - 0398, Changsha, Hunan
Local Institution - 0371, Nanjing, Jiangsu
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu
Local Institution - 0378, Yangzhou, Jiangsu
Local Institution - 0467, Nanchang, Jiangxi
The First Hospital of Jilin University, Changchun, Jilin
Local Institution - 0473, Shenyang, Liaoning
Local Institution - 0479, Shenyang, Liaoning
Local Institution - 0493, Shenyang, Liaoning
Shandong Cancer Hospital, Jinan, Shandong
LinYi Cancer Hospital, Linyi, Shandong
Local Institution - 0470, Shanghai, Shanghai
Local Institution - 0381, Shanghai, Shanghai
Local Institution - 0353, Taiyuan, Shanxi
Local Institution - 0384, Cheng Du, Sichuan
Local Institution - 0667, Chengdu, Sichuan
Tianjin Medical University General Hospital, Tianjin, Tianjin
Local Institution - 0462, Hangzhou, Zhejiang
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang
Local Institution - 0463, Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang
Shanghai East Hospital, Shanghai, Not set
Local Institution - 0580, Medellín, Antioquia
Local Institution - 0171, Rionegro, Antioquia
Local Institution - 0191, Puerto Colombia, Atlántico
Local Institution - 0253, Valledupar, Cesar
Local Institution - 0167, Montería, COR
Local Institution - 0671, Bogota, Cundinamarca
Local Institution - 0189, Bogotá, Distrito Capital De Bogotá
Local Institution - 0170, Floridablanca, Santander
Local Institution - 0173, Cali, Valle Del Cauca
Local Institution - 0619, Dubrovnik, Dubrovačko-neretvanska Županija
Local Institution - 0664, Rijeka, Primorsko-goranska Županija
Local Institution - 0639, Split, Splitsko-dalmatinska Županija
Local Institution - 0567, Osijek, Not set
Local Institution - 0585, Zagreb, Not set
Local Institution - 0159, Mulhouse, Alsace
Centre François Baclesse, Caen, Calvados
Centre Georges François Leclerc, Dijon, Côte-d'Or
CHRU de Brest, Brest, Finistère
Institut Régional du Cancer Montpellier, Montpellier, Hérault
Chu Grenoble Alpes, La Tronche, Isère
Local Institution - 0560, Angers, Maine-et-Loire
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois, Vandoeuvre lès Nancy, Meurthe-et-Moselle
Local Institution - 0636, Marseille, Provence-Alpes-Côte-d'Azur
Local Institution - 0552, Amiens, Somme
Gustave Roussy, Villejuif, Val-de-Marne
Hôpital Ambroise Paré, Boulogne-Billancourt, Not set
Chu Gabriel Montpied, Clermont-Ferrand, Not set
Local Institution - 0604, Limoges, Not set
Local Institution - 0164, Marseille, Not set
Local Institution - 0133, Paris, Not set
Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set
Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain, Not set
Klinikum Esslingen, Esslingen, Baden-Württemberg
Local Institution - 0670, Ulm, Baden-Württemberg
Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München, Bayern
Centrum für Hämatologie und Onkologie Bethanien, Frankfurt, Hessen
Local Institution - 0535, Gießen, Hessen
Praxis Onkologie am Raschplatz, Hannover, Niedersachsen
Pius Hospital Oldenburg, Oldenburg, Niedersachsen
Local Institution - 0603, Herne, Nordrhein-Westfalen
Klinikum Köln-Merheim, Köln, Nordrhein-Westfalen
Local Institution - 0522, Halle, Sachsen-Anhalt
Malteser Krankenhaus St. Franziskus-Hospital, Flensburg, Schleswig-Holstein
Local Institution - 0524, Gera, Thüringen
Universitätsklinikum Jena, Jena, Thüringen
Vivantes Klinikum Neukölln, Berlin, Not set
Local Institution - 0537, Berlin, Not set
Local Institution - 0675, Halle, Not set
Local Institution - 0528, Hemer, Not set
Local Institution - 0517, Stuttgart, Not set
Local Institution - 0525, Wuerzburg, Not set
Local Institution - 0608, Athens, Attikí
Local Institution - 0612, Athens, Attikí
Local Institution - 0609, Larissa, Thessalía
Queen Mary Hospital, Hksar, Not set
Queen Mary Hospital, Hksar, Not set
Local Institution - 0601, Gyor, Győr-Moson-Sopron
Local Institution - 0144, Gyöngyös, Heves
Local Institution - 0157, Tatabánya, Komárom-Esztergom
Local Institution - 0593, Kaposvár, Somogy
Local Institution - 0143, Farkasgyepu, Veszprém
Local Institution - 0151, Budapest, Not set
Local Institution - 0140, Budapest, Not set
Local Institution - 0222, Visakhapatnam, Andhra Pradesh
Local Institution - 0312, New Delhi, Delhi
Local Institution - 0511, New Delhi, Delhi
Local Institution - 0135, New Delhi, Delhi
Local Institution - 0136, Ahmedabad, Gujarat
Local Institution - 0230, Ahmedabad, Gujarat
Local Institution - 0155, Thiruvananthapuram, Kerala
Local Institution - 0154, Mumbai, Maharashtra
Local Institution - 0226, Bhubaneswar, Odisha
Local Institution - 0224, Madurai, Tamil Nadu
Local Institution - 0663, Hyderabad, Telangana
Local Institution - 0153, Varanasi, Uttar Pradesh
Local Institution - 0161, Howrah, West Bengal
Local Institution - 0221, Kolkata, West Bengal
Local Institution - 0661, Hyderabad, Not set
Local Institution - 0102, Cork, Not set
Mater Private Hospital - Dublin, Dublin, Not set
Local Institution - 0101, Dublin, Not set
Local Institution - 0100, Dublin, Not set
Local Institution - 0106, Dublin, Not set
Local Institution - 0597, Petah Tikva, HaMerkaz
Local Institution - 0596, Ramat Gan, HaMerkaz
Yitzhak Shamir Medical Center, Zerifin, HaMerkaz
Hadassah Medical Center, Jerusalem, Yerushalayim
Local Institution - 0613, Haifa, Ḥeifā
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Emilia-Romagna
Local Institution - 0066, Naples, Napoli
Local Institution - 0070, Orbassano, Piemonte
Local Institution - 0071, Bari, Puglia
Local Institution - 0068, Rome, Roma
Local Institution - 0069, Firenze, Toscana
Local Institution - 0588, Genova, Not set
Local Institution - 0073, Padova, Not set
Local Institution - 0156, Parma, Not set
Local Institution - 0543, Pavia, Not set
Local Institution - 0556, Varese, Not set
Local Institution - 0607, Nagoya, Aichi
Local Institution - 0305, Nagoya, Aichi
Local Institution - 0298, Sapporo, Hokkaido
Local Institution - 0304, Kanazawa, Ishikawa
Local Institution - 0302, Sagamihara, Kanagawa
Local Institution - 0369, Yokohama, Kanagawa
Local Institution - 0301, Sendai, Miyagi
Local Institution - 0306, Kashihara, Nara
Local Institution - 0368, Kurashiki, Okayama
Local Institution - 0642, Hirakata, Osaka
Local Institution - 0303, Hidaka, Saitama
Local Institution - 0300, Ina-machi, Saitama
Local Institution - 0606, Hamamatsu, Shizuoka
Local Institution - 0299, Shimotsuga, Tochigi
Local Institution - 0343, Toyoma, Toyama
Local Institution - 0542, Iwakuni, Yamaguchi
Local Institution - 0307, Akashi, Not set
Local Institution - 0346, Aomori, Not set
Local Institution - 0310, Fukuoka, Not set
Local Institution - 0367, Fukushima, Not set
Local Institution - 0308, Kumamoto, Not set
Local Institution - 0297, Osaka, Not set
Local Institution - 0309, Osaka, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]
Gachon University Gil Medical Center, Namdong-gu, Incheon-gwangyeoksi [Incheon]
Pusan National University Yangsan Hospital, Yangsan, Kyǒngsangnam-do
Pusan National University Hospital, Busan, Pusan-Kwangyǒkshi
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]
Konkuk University Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Korea University Guro Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0583, Saltillo, Coahuila
Local Institution - 0176, Mexico City, DIF
Local Institution - 0579, Pachuca, Hidalgo
Local Institution - 0178, Guadalajara, Jalisco
Local Institution - 0591, Monterrey, Nuevo León
Local Institution - 0175, Chihuahua, Not set
Local Institution - 0181, Puebla, Not set
Local Institution - 0638, Puebla, Not set
Local Institution - 0180, Veracruz, Not set
Local Institution - 0615, Maastricht, Limburg
Local Institution - 0594, Amsterdam, Noord-Holland
Local Institution - 0205, Wrocław, Dolnośląskie
Local Institution - 0080, Lublin, Lubelskie
Local Institution - 0206, Gorlice, Małopolskie
Local Institution - 0079, Kraków, Małopolskie
Med-Polonia Sp. z o. o., Poznan, Wielkopolskie
Centrum Onkologii im. Prof. Franciszka Lukaszczyka, Bydgoszcz, Not set
Local Institution - 0078, Katowice, Not set
Szpital Specjalistyczny w Prabutach Spolka z o.o., Prabuty, Not set
Local Institution - 0509, Lisbon, Lisboa
Local Institution - 0510, Coimbra, Not set
Local Institution - 0553, Porto, Not set
SC Memorial Healthcare International SRL, Bucharest, București
Institutul Oncologic Bucuresti, Bucharest, București
Local Institution - 0276, Cluj-Napoca, Cluj
SC Radiotherapy Center Cluj SRL, Florești, Cluj
Ovidius Clinical Hospital OCH, Ovidiu, Constanța
Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj
Spitalul Municipal Schuller Ploiești, Ploiești, Prahova
Cabinet Medical Oncomed, Timișoara, Timiș
Institutul Oncologic Cluj, Cluj, Not set
Local Institution - 0270, Cluj, Not set
Affidea Constanța, Constanța, Not set
S.C. Centrul de Oncologie Euroclinic S.R.L., Iași, Not set
Institutul Regional de Oncologie, Iași, Not set
Local Institution - 0614, Jeddah, Makkah Al Mukarramah
Local Institution - 0602, Riyadh, Not set
Local Institution - 0562, Riyadh, Not set
Local Institution - 0499, A Coruña, A Coruña [La Coruña]
Local Institution - 0506, Santiago de Compostela, A Coruña [La Coruña]
Local Institution - 0501, Barcelona, Barcelona [Barcelona]
Local Institution - 0497, Hospitalet, Barcelona [Barcelona]
Local Institution - 0505, Barcelona, Catalunya [Cataluña]
Hospital Son Llàtzer, Palma, Illes Balears [Islas Baleares]
Local Institution - 0500, Madrid, Madrid, Comunidad De
Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad De
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De
Local Institution - 0669, Pontevedra, Pontevedra [Pontevedra]
Hospital Arnau de Vilanova, Valencia, València
Hospital Clinico San Carlos, Madrid, Not set
H.R.U Málaga - Hospital General, Málaga, Not set
Hospital Universitario Virgen Del Rocio, Sevilla, Not set
Local Institution - 0495, València, Not set
Kantonsspital Münsterlingen - Spital Thurgau AG, Münsterlingen, Not set
Chi Mei Hospital - Liouying Branch, Tainan City, Tainan
Tri-Service General Hospital, Taipei City, Taipei
Taipei Medical University Shuang Ho Hospital, New Taipei, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Local Institution - 0565, Muang, Khon Kaen
Local Institution - 0563, Bangkok, Krung Thep Maha Nakhon
Local Institution - 0564, Hatyai, Songkhla
Local Institution - 0548, Stanbul, İstanbul
Local Institution - 0199, Izmir, Karsiyaka, İzmir
Local Institution - 0197, Adana, Not set
Local Institution - 0201, Ankara, Not set
Local Institution - 0194, Ankara, Not set
Local Institution - 0198, Ankara, Not set
Local Institution - 0550, Istanbul, Not set
Local Institution - 0549, Istanbul, Not set
Local Institution - 0200, Izmir, Not set
University College London Hospital, London, London, City Of
Guy's & St Thomas' NHS Foundation Trust, London, London, City Of
Local Institution - 0092, Birmingham, Not set
Local Institution - 0090, Guildford, Not set
Local Institution - 0545, Guildford, Not set
Local Institution - 0093, Manchester, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)
Active Not Recruiting
This study consists of several parts: dose escalation, dose expansion, dose expansion in Chinese participants residing in China, and coformulation. Dose escalation is to evaluate the safety, tolerability, and preliminary efficacy of MK-4830 monotherapy administration (Arms A and B) and in combination with pembrolizumab (Arm C). Dose expansion is to evaluate the objective response rate (ORR) of MK-4830 in combination with pembrolizumab (Arms A-F); evaluate the safety and tolerability of MK-4830 a... Read More
This study consists of several parts: dose escalation, dose expansion, dose expansion in Chinese participants residing in China, and coformulation. Dose escalation is to evaluate the safety, tolerability, and preliminary efficacy of MK-4830 monotherapy administration (Arms A and B) and in combination with pembrolizumab (Arm C). Dose expansion is to evaluate the objective response rate (ORR) of MK-4830 in combination with pembrolizumab (Arms A-F); evaluate the safety and tolerability of MK-4830 administered in combination with pembrolizumab, carboplatin, and pemetrexed (Arm G) and of MK-4830 administered in combination with pembrolizumab and lenvatinib (Arm H); evaluate the safety, tolerability and ORR of MK-4830 in combination with pembrolizumab plus chemotherapy (Arms I-L); and evaluate the safety and tolerability of MK-4830 in combination with pembrolizumab in Chinese participants from China (Arm M). The coformulation part (Arm N) evaluates the safety and tolerability of MK-4830A (coformulation of MK-4830 800 mg + pembrolizumab 200 mg). There is no formal hypothesis testing in this study. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/23/2025
Locations: University of California at San Francisco ( Site 0004), San Francisco, California +36 locations
University of California at San Francisco ( Site 0004), San Francisco, California
Henry Ford Health System ( Site 0002), Detroit, Michigan
Washington University ( Site 0003), Saint Louis, Missouri
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0005), Hackensack, New Jersey
Laura and Isaac Perlmutter Cancer Center ( Site 0008), New York, New York
Ohio State University Arthur G James Cancer Hospital & Richard J Solove Research Institute ( Site 00, Columbus, Ohio
South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001), San Antonio, Texas
Utah Cancer Specialists ( Site 0011), Salt Lake City, Utah
Seattle Cancer Care Alliance ( Site 0010), Seattle, Washington
Liverpool Hospital-Medical Oncology ( Site 0250), Liverpool, New South Wales
Princess Alexandra Hospital ( Site 0253), Brisbane, Queensland
Juravinski Cancer Centre ( Site 0034), Hamilton, Ontario
The Ottawa Hospital ( Site 0031), Ottawa, Ontario
Princess Margaret Cancer Centre ( Site 0033), Toronto, Ontario
The First Hospital of Jilin University ( Site 0803), Changchun, Jilin
Shanghai Chest Hospital-Oncology department ( Site 0801), Shanghai, Shanghai
West China Hospital of Sichuan University ( Site 0804), Chengdu, Sichuan
Hôpital Européen Georges Pompidou ( Site 2003), Paris, Ile-de-France
Centre Oscar Lambret ( Site 2002), Lille, Nord
Centre Hospitalier Universitaire de Poitiers ( Site 2000), Poitiers, Vienne
University General Hospital of Heraklion ( Site 0110), Heraklion, Irakleio
Euromedica General Clinic of Thessaloniki-Oncology Unit ( Site 0112), Thessaloniki, Not set
European Interbalkan Medical Center ( Site 0111), Thessaloniki, Not set
Rambam Health Care Campus-Oncology Division ( Site 0042), Haifa, Not set
Rabin Medical Center ( Site 0043), Petah Tikva, Not set
Chaim Sheba Medical Center. ( Site 0044), Ramat Gan, Not set
Sourasky Medical Center ( Site 0041), Tel Aviv, Not set
National Cancer Center Hospital East ( Site 0400), Kashiwa, Chiba
Japanese Foundation for Cancer Research ( Site 0401), Tokyo, Not set
Severance Hospital Yonsei University Health System ( Site 0300), Seoul, Not set
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie
Uniwersyteckie Centrum Kliniczne ( Site 0151), Gdansk, Pomorskie
Wits Clinical Research ( Site 0213), Johannesburg, Gauteng
The Oncology Centre ( Site 0212), Durban, Kwazulu-Natal
Cancercare Rondebosch Oncology ( Site 0210), Cape Town, Western Cape
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 0101), Hospitalet de Llobregat, Barcelona
Centro Integral Oncologico Clara Campal START Madrid ( Site 0102), Madrid, Not set
Conditions: Neoplasms
A Study of MK-1084 in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
Recruiting
This is a study evaluating the safety, pharmacokinetics, and efficacy of MK-1084 alone, and MK-1084 plus other combination therapies in participants with advanced solid tumors with identified kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation.
This is a study evaluating the safety, pharmacokinetics, and efficacy of MK-1084 alone, and MK-1084 plus other combination therapies in participants with advanced solid tumors with identified kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/23/2025
Locations: Moffitt Cancer Center ( Site 0261), Tampa, Florida +70 locations
Moffitt Cancer Center ( Site 0261), Tampa, Florida
START Midwest ( Site 0267), Grand Rapids, Michigan
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0260), Hackensack, New Jersey
Laura and Isaac Perlmutter Cancer Center ( Site 0270), New York, New York
NEXT Virginia ( Site 0271), Fairfax, Virginia
MEDICAL COLLEGE OF WISCONSIN-Cancer Center Clinical Trials Office ( Site 0262), Milwaukee, Wisconsin
Chris O'Brien Lifehouse ( Site 0002), Camperdown, New South Wales
Liverpool Hospital-Medical Oncology ( Site 0001), Liverpool, New South Wales
Westmead Hospital ( Site 0006), Westmead, New South Wales
Monash Health-Oncology Research ( Site 0003), Clayton, Victoria
Cross Cancer Institute ( Site 0033), Edmonton, Alberta
The Moncton Hospital ( Site 0037), Moncton, New Brunswick
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0030), Hamilton, Ontario
Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 0036), Kingston, Ontario
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0032), Toronto, Ontario
James Lind Centro de Investigacion del Cancer ( Site 0043), Temuco, Araucania
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0041), Santiago., Region M. De Santiago
FALP-UIDO ( Site 0040), Santiago, Region M. De Santiago
Bradfordhill ( Site 0042), Santiago, Region M. De Santiago
Beijing Friendship Hospital Affiliate of Capital University-Oncology ( Site 0417), Beijing, Beijing
Fujian Cancer Hospital ( Site 0419), Fuzhou, Fujian
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 0413), Guangzhou, Guangdong
Sun Yat-sen University Cancer Center-Internal medicine ( Site 0415), Guangzhou, Guangdong
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0418), Wuhan, Hubei
Jilin Cancer Hospital-oncology department ( Site 0412), Changchun, Jilin
Shanghai Chest Hospital-Oncology department ( Site 0410), Shanghai, Shanghai
Shanghai East Hospital ( Site 0416), Shanghai, Shanghai
Zhejiang Cancer Hospital-Thoracic oncology ( Site 0411), Hangzhou, Zhejiang
Odense Universitetshospital-Department of oncology ( Site 0421), Odense, Syddanmark
Rambam Health Care Campus-Oncology ( Site 0090), Haifa, Not set
Shaare Zedek Medical Center-Oncology ( Site 0092), Jerusalem, Not set
Hadassah Medical Center-Oncology ( Site 0094), Jerusalem, Not set
Meir Medical Center. ( Site 0091), Kfar Saba, Not set
Sheba Medical Center-ONCOLOGY ( Site 0093), Ramat Gan, Not set
Humanitas ( Site 0113), Rozzano, Lombardia
ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 0111), Siena, Toscana
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 0110), Napoli, Not set
National Cancer Center Hospital East ( Site 0404), Kashiwa, Chiba
Kanagawa Cancer Center ( Site 0402), Yokohama, Kanagawa
Shizuoka Cancer Center ( Site 0401), Nagaizumi, Shizuoka
National Cancer Center Hospital ( Site 0403), Chuo-ku, Tokyo
Cancer Institute Hospital of JFCR ( Site 0400), Koto, Tokyo
Seoul National University Hospital ( Site 0191), Seoul, Not set
Samsung Medical Center-Division of Hematology/Oncology ( Site 0193), Seoul, Not set
Hospital of Lithuanian University of Health Sciences Kauno klinikos ( Site 0121), Kaunas, Kauno Apskritis
Sarawak General Hospital ( Site 0453), Kuching, Sarawak
New Zealand Clinical Research (Christchurch) ( Site 0004), Christchurch, Canterbury
Centro Oncologico de Panama ( Site 0160), Panama City, Not set
Centro Hemato Oncológico Paitilla ( Site 0163), Panama City, Not set
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Oddzial Badan Wczesnych Faz ( Site 0170), Warszawa, Mazowieckie
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0171), Gdansk, Pomorskie
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 0172), Poznan, Wielkopolskie
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0173), Koszalin, Zachodniopomorskie
Clinica Universidad de Navarra ( Site 0213), Madrid, Madrid, Comunidad De
Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD ( Site 0211), Madrid, Madrid, Comunidad De
Hospital Universitari Vall d'Hebron-Oncology ( Site 0212), Barcelona, Not set
Cantonal Hospital St.Gallen ( Site 0224), St.Gallen, Sankt Gallen
Ospedale Regionale Bellinzona e Valli ( Site 0220), Bellinzona, Ticino
Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 0445), Kaohsiung Niao Sung Dist, Kaohsiung
National Cheng Kung University Hospital ( Site 0444), Tainan, Not set
National Taiwan University Hospital-Oncology ( Site 0443), Taipei, Not set
Ege University Medicine of Faculty ( Site 0231), Bornova, Izmir
Erciyes University ( Site 0232), Talas, Kayseri
Hacettepe Universite Hastaneleri-oncology hospital ( Site 0234), Ankara, Not set
Ankara City Hospital-oncology ( Site 0233), Ankara, Not set
MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 0254), Cherkasy, Cherkaska Oblast
Communal Non-Commercial Enterprise Prykarpatski Clinical Onc-Chemotherapy department ( Site 0251), Ivano-Frankivsk, Ivano-Frankivska Oblast
Private Enterprise Private Manufacturing Company Acinus-Medical and Diagnostic Centre ( Site 0255), Kropyvnytskyi, Kirovohradska Oblast
Rivne Regional Clinical Hospital ( Site 0257), Rivne, Rivnenska Oblast
ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 0259), Rivne, Rivnenska Oblast
Uzhhorod Multispecialty City Clinical Hospital ( Site 0258), Uzhhorod, Zakarpatska Oblast
Conditions: Advanced Solid Tumors
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
Recruiting
The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative to pembrolizumab (PEMBRO) in combination with chemotherapy on overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actionable genomic alteration.
The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative to pembrolizumab (PEMBRO) in combination with chemotherapy on overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actionable genomic alteration. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/21/2025
Locations: Palo Verde Hematology Oncology Ltd, Glendale, Arizona +226 locations
Palo Verde Hematology Oncology Ltd, Glendale, Arizona
California Cancer Associates for Research and Excellence, San Marcos, California
Texas Oncology, Santa Barbara, California
Innovative Clinical Research Institute, Whittier, California
Eastern CT Hematology and Oncology Associates, Norwich, Connecticut
George Washington Medical Faculty Associates, Washington, District of Columbia
Lake City Cancer Care, Lake City, Florida
Florida Cancer Specialists, Sarasota, Florida
Moffitt Cancer Center, Tampa, Florida
Peachtree Hematology Oncology Consultants, Atlanta, Georgia
Illinois Cancer Care, Peoria, Illinois
Messino Cancer Centers, Asheville, North Carolina
Oncology Hematology Care, Inc., Cincinnati, Ohio
Hematology & Oncology Associates, Eugene, Oregon
AHN Allegheny General Hospital, Pittsburgh, Pennsylvania
Arlington Cancer Center, Arlington, Texas
Texas Oncology - Austin, Austin, Texas
Texas Oncology, Dallas, Texas
Texas Oncology- Denison, Sherman, Texas
US Oncology Investigational Products Center (IPC), Arlington, Virginia
Oncology and Hematology Associates of Southwest Virginia, Inc, Blacksburg, Virginia
Northwest Cancer Specialists, PC, Vancouver, Washington
Investigaciones CORI S.R.L., Capital, Not set
Centro Médico Privado Centro de Especialidades Médicas Ambulatorias e Investigación Clínica, Cardoba, Not set
Centro Medico Barrio Parque, Ciudad Autanoma Buenos Aires, Not set
Sanatorio Allende, Cordoba, Not set
Sanatorio Britanico de Rosario, Rosario, Not set
Sanatorio Parque de Rosario, Rosario, Not set
Hospital Provincial del Centenario, Rosario, Not set
Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Not set
CAIPO - Centro para la Atención Integral del Paciente Oncológico, San Miguel de Tucumán, Not set
Clínica Viedma, Viedma, Not set
Klinikum Klagenfurt am Woerthersee, Klagenfurt Am Woerthersee, Not set
Ordensklinikum Linz GmbH, Elisabethinen, Linz, Not set
Klinikum Wels-Grieskirchen, Wels, Not set
Krankenhaus Nord - Klinik Floridsdorf, Wien, Not set
Algemeen Ziekenhuis Sint-Lucas, Aalst, Not set
Grand Hopital de Charleroi asbl (GHdC), Charleroi, Not set
AZ Sint-Maarten, Mechelen, Not set
CHU UCL Namur / Site Sainte Elisabeth, Namur, Not set
Cenantron Centro Avançado de Tratamento Oncologico Ltda, Belo Horizonte, Not set
Hospital Evangelico de Cachoeiro de Itapemirim, Cachoeiro De Itapemirim, Not set
Fundacao Universidade De Caxias Do Sul - FUCS/RS, Caxias Do Sul, Not set
Instituto do Câncer do Ceará - ICC, Fortaleza, Not set
Oncosite - Centro de Pesquisa Clinica em Oncologia LTDA, Ijui, Not set
Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Not set
Hospital de Clínicas de Porto Alegre, Porto Alegre, Not set
Hospital São Lucas da PUCRS, Porto Alegre, Not set
Hospital Ana Nery Santa Cruz do Sul, Santa Cruz Do Sul, Not set
Centro Des Pesquisas Clinicas da Fundacao Doutor Amaral Carvalho, Sao Paolo, Not set
Instituto Brasiliero de Controle do Cancer IBCC, Sao Paulo, Not set
Centre Integre de sante et de services sociaux de la Monteregie Centre, Greenfield Park, Not set
Moncton Hospital, Moncton, Not set
CISSS des Laurentides, Quebec, Not set
Centre de santé et services sociaux de Rimouski-Neigette, Rimouski, Not set
BC Cancer - Victoria, Victoria, Not set
Clinica Alemana de Santiago, Las Condes, Not set
Orlandioncologia, Providencia, Not set
Oncovida- Santiago, Providencia, Not set
Clinica Puerto Montt, Puerto Montt, Not set
Biocinetic, Santiago, Not set
James Lind Centro de Investigacion del Cancer, Temuco, Not set
Oncocentro APYS, Vina del Mar, Not set
West China Hospital Sichuan University, Chengdu, Not set
Chongqing University Cancer Hospital, Chongqing, Not set
Deyang People's Hospital, Deyang, Not set
Fujian Cancer Hospital, Fuzhou, Not set
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Not set
Guangzhou First People's Hospital, Guangzhou, Not set
Nanfang Hospital, Southern Medical University, Guangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou, Not set
Anhui Chest Hospital, Hefei, Not set
The Second Affiliated Hospital of Nanchang University, Jiangxi, Not set
Shandong Cancer Hospital, Jinan, Not set
Jiangxi Chest Hospital, Nanchang, Not set
Nanjing Drum Tower Hospital, Nanjing, Not set
Guangxi Medical University Cancer Hospital, Nanning, Not set
Shanghai Chest Hospital, Shanghai, Not set
Shanghai East Hospital, Shanghai, Not set
Shanghai Pulmonary Hospital, Shanghai, Not set
Cancer Hospital of Shantou University Medical College, Shantou, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Not set
Tongji Hospital Tongji Medical College of Hust, Wuhan, Not set
The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Not set
The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Not set
Henan Cancer Hospital, Zhengzhou, Not set
Ambroise-Pare Hospital, Assistance Publique - Hopitaux de Paris, Boulogne-Billancourt, Not set
CHU de Caen, Caen, Not set
Clinique Victor Hugo, Centre de Cancerologie de la Sarthe, Le Mans, Not set
Hopital Nord, Marseille, Not set
Institut de Cancer de Montpellier (ICM) - Val d'Aurelle, Montpellier, Not set
Centre Antoine Lacassagne, Nice, Not set
Institut de cancerologie de l'ouest (ICO), Saint-Herblain, Not set
Hopital d'Instruction des Armees (HIA) Begin, Saint-Mandé, Not set
Centre Hospitalier de Saint-Quentin, Saint-Quentin, Not set
Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, Not set
Hôpital Foch, Suresnes, Not set
CHI de Toulon la Seyne-sur-Mer Hopital Sainte Musse, Toulon cedex, Not set
Augusta-Kranken-Anstalt gGmbh Klinik für Hämatologie Onkologie und Palliativmedizin, Bochum, Not set
Klinikum Chemnitz gGmbH, Chemnitz, Not set
Universitatsklinikum Essen / Westdeutsches Tumorzentrum, Innere Klinik (Tumorforschung), Essen, Not set
Universitätsklinikum Freiburg, Klinik für Innere Medizin I Hämatologie, Onkologie und Stammzelltransplantation, Freiburg, Not set
LungenClinic Grosshansdorf, Grosshansdorf, Not set
Krankenhaus Martha-Maria Halle Dölau, Halle, Not set
Asklepios Kliniken Hamburg, Hamburg, Not set
Katholisches Marienkrankenhaus gGmbH, Hamburg, Not set
Lungenklinik Hemer, Zentrum fur Pneumologie and Thoraxchirurgie, Hemer, Not set
Vincentius-Diakonissen-Kliniken gAG, St. Vincentius-Kliniken, Medizinische Klinik 2, Karlsruhe, Not set
Klinikum Kassel, Kassel, Not set
Kliniken der Stadt Köln ggmbh, Krankenhaus Koln-Merheim/Lungenklinik, Köln, Not set
Universitatsklinikum Schleswig-Holstein, Lubeck, Not set
Johannes Wesling Klinikum Minden, Minden, Not set
Munchen Klinik Bogenhausen, Klinik fur Pneumologie und Pneumologische Onkologie, Munchen, Not set
Sana Klinikum Offenbach GmbH, Medizinische Klinik IV, Hämatologie und Internistische Onkologie, Offenbach, Not set
Queen Elizabeth Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Prince of Wales Hospital, New Territories, Not set
Soroka University Medical Center, Itzchak Rager Blvd., Beer Seva, Not set
Shaare Zedek Medical Center, Jerusalem, Not set
Oncology Institute, Galilee Medical Center, Route 89 Nahariya-Cabri, Nahariya, Not set
Rabin Medical Center, Petah Tiqva, Not set
Kaplan Medical Center, Rehovot, Not set
Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set
Azienda Ospedaliera San Giuseppe Moscati, Avellino, Not set
IRCCS Fondazoine del Piemonte per l'Oncologia, Candiolo, Not set
Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Not set
Ospedale Policlinico San Martino, Genova, Not set
Ospedale San Raffaele, Milano, Not set
Azienda Ospedaliero Universitaria di Modena, Modena, Not set
AORN Cardarelli, Naples, Not set
Azienda Ospedaliera dei Colli, Napoli, Not set
IRCCS Policlinico S. Matteo, Dipartimento Oncologia Ematologia-Oncologia Medica, Pavia, Not set
Azienda Sanitaria Territoriale Pesaro e Urbino (AST), Pesaro, Not set
Ospedale Guglielmo da Saliceto AUSL di Piacenza, Piacenza, Not set
Centro di Riferimento Oncologico, Pordenone, Not set
Regina Elena Institute for Cancer Research, Rome, Not set
ASST Bergamo Ovest- ospedale di Treviglio, Treviglio, Not set
National Cancer Center Hospital East, Chiba, Not set
National Hospital Organization Shikoku Cancer Center, Ehime, Not set
Kyushu University Hospital, Fukuoka, Not set
Kurume University Hospital, Fukuoka, Not set
National Hospital Organization Himeji Medical Center, Hyogo, Not set
Hyogo Cancer Center, Hyogo, Not set
Kanazawa University Hospital, Ishikawa, Not set
Kanagawa Cancer Center, Kanagawa, Not set
Sendai Kousei Hospital, Miyagi, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Osaka Metropolitan University Hospital, Osaka, Not set
Osaka Medical and Pharmaceutical University Hospital, Osaka, Not set
Kindai University Hospital, Osaka, Not set
National Hospital Organization Kinki Chuo Chest Medical Center, Osaka, Not set
Saitama Medical University, Saitama, Not set
SMG - SNU Boramae Medical Center, Dongjak-Gu, Not set
Samsung Medical Center, Gangnam-Gu, Not set
National Cancer Center, Goyang, Not set
Chungbuk National University Hospital, Heungdeok-Gu, Not set
Inha University Hospital, Incheon, Not set
Gachon University Gil Medical Center, Inchon, Not set
Kosin University Gospel Hospital, Seo-gu, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set
Ajou University Hospital, Suwon-si, Not set
The Catholic University of Korea, Saint Vincent's Hospital, Suwon, Not set
Health Pharma Professional Research S.A. de C.V., Mexico, Not set
Hospital Universitario Dr. Jose Eleuterio Gonzalez, Mitras Centro, Not set
Oaxaca Site Management Organization, Oaxaca, Not set
Centro de Investigacion Clinica de Oaxaca, Oaxaca, Not set
Clinical Medical Research SC., Orizaba Centro, Not set
Clinica Integral Internacional de Oncologia S de RL de CV, Puebla, Not set
FAICIC Clínical Research, Veracruz, Not set
Amphia Ziekenhuis, Breda, Not set
Ziekenhuis Gelderse Vallei, Ede, Not set
Universitair Medisch Centrum Groningen, Groningen, Not set
Ziekenhuis St Jansdal, Harderwijk, Not set
TweeSteden Ziekenhuis, Tilburg, Not set
Hospital Prof. Doutor Fernando Fonseca, Amadora, Not set
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Not set
Fundacao Champalimaud, Lisboa, Not set
Centro Hospitalar Universitário Lisboa Norte - Hospital Pulido Valente, Lisboa, Not set
Hospital Beatriz Angelo. Hospital de Loures., Lisbon, Not set
Centro Hospitalar Universitario Sao Joao, EPE, Porto, Not set
Unidade Local de Saude de Matosinhos EPE - Hospital Pedro Hispano SA, Senhora da Hora, Not set
Raffles Hospital, Singapore, Not set
Tang Tock Seng Hospital, Singapore, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital de la Santa Creu i de Sant Pau, Barcelona, Not set
Hospital Universitari Dexeus (USP Institut Universitari Dexeus/Hospital Universitari Quiron Dexeus), Barcelona, Not set
Hospital Universitari Vall D'Hebron, Barcelona, Not set
Hospital Parc Tauli, Barcelona, Not set
Hospital Universitario Reina Sofia, Cordoba, Not set
Hospital Doctor Josep Trueta, Girona, Not set
Hospital Universitario de Jaen, Jaen, Not set
Hospital Universitario de Canarias, Las Palmas de G.C., Not set
Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set
Clinica Universidad de Navarra, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Not set
Hospital Sant Joan de Reus, Reus, Not set
Hospital Regional Universitario de Malaga, Rincon de la Victoria, Not set
Hospital Universitario Virgen Macarena, Sevilla, Not set
Hospital Universitario Virgen del Rocio, Seville, Not set
Instituto Valenciano De Oncologia (IVO), Valencia, Not set
Hospital Universitari i Politecnic La Fe, Valencia, Not set
Hospital Vithas Valencia 9 de Octubre, Valencia, Not set
Changhua Christian Hospital, Changhua City, Not set
E-DA Hospital, Kaohsiung City, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set
Chang Gung Memorial Hospital Kaohsiung, Kaohsiung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Chi Mei Hospital, Liouying, Tainan, Not set
National Taiwan University Hospital, Taipei City, Not set
Taipei Veterans General Hospital, Taipei, Not set
Chang Gung Memorial Hospital Linkou Branch of the Chang Gung Medical Foundation, Taoyuan City, Not set
Ankara Bilkent Sehir Hastanesi, Ankara, Not set
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara, Not set
Trakya University Faculty of Medicine, Edirne, Not set
Istanbul University Cerrahpasa Medical Faculty Hospital, Fatih, Not set
Goztepe Prof. Dr. Suleyman Yalcın Sehir Hastanesi, Istanbul, Not set
Medipol Mega University Hospital, Istanbul, Not set
Acibadem Mehmet Ali Aydinlar Universitesi Atakent Hastanesi, Kaakaekmece, Not set
Turgut Ozal Medical Faculty, Malatya, Not set
Colchester General Hospital, Colchester, Not set
St Bartholomew's Hospital, Barts Health NHS Trust, London, Not set
The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, Not set
University Hospital Southampton Nhs Foundation Trust, Southampton, Not set
Conditions: Non-small Cell Lung Cancer
Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)
Completed
The purpose of this study is to evaluate the use of investigational agents (MK-4830, boserolimab (MK-5890) and lenvatinib (MK-7902)) in combination with pembrolizumab (MK-3475) and etoposide/platinum chemotherapy for the first-line treatment of participants with extensive-stage small cell Lung Cancer (ES-SCLC). No formal hypothesis testing will be performed for this study.
The purpose of this study is to evaluate the use of investigational agents (MK-4830, boserolimab (MK-5890) and lenvatinib (MK-7902)) in combination with pembrolizumab (MK-3475) and etoposide/platinum chemotherapy for the first-line treatment of participants with extensive-stage small cell Lung Cancer (ES-SCLC). No formal hypothesis testing will be performed for this study. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/21/2025
Locations: Banner MD Anderson Cancer Center ( Site 0102), Gilbert, Arizona +48 locations
Banner MD Anderson Cancer Center ( Site 0102), Gilbert, Arizona
University of Colorado Anschutz Medical Campus ( Site 0104), Aurora, Colorado
Georgia Cancer Specialists ( Site 0106), Atlanta, Georgia
Parkview Research Center at Parkview Regional Medical Center ( Site 0130), Fort Wayne, Indiana
Baptist Health Lexington-Research ( Site 0108), Lexington, Kentucky
MFSMC-HJWCI-Oncology Research ( Site 0128), Baltimore, Maryland
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0122), Omaha, Nebraska
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0129), Omaha, Nebraska
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0114), Mineola, New York
Memorial Sloan Kettering Cancer Center ( Site 0115), New York, New York
Cleveland Clinic-Taussig Cancer Center ( Site 0116), Cleveland, Ohio
UPMC Hillman Cancer Center ( Site 0127), Pittsburgh, Pennsylvania
St Francis Cancer Center-Research Office ( Site 0117), Greenville, South Carolina
Virginia Cancer Institute ( Site 0119), Richmond, Virginia
Klinik Penzing-2. Lungenabteilung ( Site 2101), Vienna, Wien
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2100), Wien, Not set
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2003), Hamilton, Ontario
Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 2005), Kingston, Ontario
St. Marys Hospital Center ( Site 2000), Montreal, Quebec
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 2800), Szolnok, Jasz-Nagykun-Szolnok
Országos Korányi Pulmonológiai Intézet-XIV. Tüdöbelgyógyászat ( Site 2806), Budapest, Pest
Torokbalint Tudogyogyintezet-Onkopulmonologiai Jarobeteg Centrum ( Site 2801), Törökbálint, Pest
Zala Megyei Szent Rafael Kórház-Pulmonológia ( Site 2805), Zalaegerszeg, Zala
Semmelweis University-Pulmonológiai Klinika ( Site 2802), Budapest, Not set
Rambam Health Care Campus-Oncology ( Site 2600), Haifa, Not set
Shaare Zedek Medical Center ( Site 2602), Jerusalem, Not set
Meir Medical Center ( Site 2601), Kfar Saba, Not set
Rabin Medical Center-Oncology ( Site 2604), Petah Tikva, Not set
Sheba Medical Center-ONCOLOGY ( Site 2603), Ramat Gan, Not set
Ospedale San Raffaele-Oncologia Medica ( Site 2303), Milano, Lombardia
ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 2300), Siena, Toscana
Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 2304), Milano, Not set
Chungbuk National University Hospital ( Site 1107), Cheongju-si, Chungbuk
Seoul National University Bundang Hospital ( Site 1104), Seongnam, Kyonggi-do
The Catholic University Of Korea St. Vincent's Hospital ( Site 1106), Suwon-si, Kyonggi-do
Seoul National University Hospital ( Site 1101), Seoul, Not set
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1105), Seoul, Not set
Asan Medical Center-Department of Oncology ( Site 1103), Seoul, Not set
Samsung Medical Center ( Site 1100), Seoul, Not set
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier, Warszawa, Mazowieckie
Samodzielny Publiczny Zespó Grulicy i Chorób Puc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemi, Olsztyn, Warminsko-mazurskie
Krasnoyarsk Regional Oncology Dispensary, Named after Krizhanovsky ( Site 2708), Krasnoyarsk, Krasnoyarskiy Kray
N.N.Petrov Research Institute of Oncology-Department of Chemotherapy and Innovative Technologies ( S, Saint Petersburg, Sankt-Peterburg
GBUZ "SPb CRPCstmc(o)" ( Site 2705), Saint-Petersburg, Sankt-Peterburg
Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 2704), Sankt-Peterburg, Not set
Instituto Catalan de Oncologia - Hospital Duran i Reynals ( Site 2403), L'Hospitalet de Llobregat, Cataluna
Hospital Insular de Gran Canaria ( Site 2402), Las Palmas de Gran Canaria, Las Palmas
Hospital Universitari Vall d'Hebron-Oncology ( Site 2401), Barcelona, Not set
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 2502), st.Gallen, Sankt Gallen
Conditions: Small Cell Lung Cancer
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
Recruiting
This study aims to establish a safe and well tolerated dose of \[177Lu\]Lu-DOTA-TATE in combination with carboplatin, etoposide and atezolizumab in this setting and to assess preliminary efficacy of this combination treatment versus the combination of carboplatin, etoposide, and atezolizumab.The study will be essential to assess a new potential therapeutic option in participants with this aggressive cancer type.
This study aims to establish a safe and well tolerated dose of \[177Lu\]Lu-DOTA-TATE in combination with carboplatin, etoposide and atezolizumab in this setting and to assess preliminary efficacy of this combination treatment versus the combination of carboplatin, etoposide, and atezolizumab.The study will be essential to assess a new potential therapeutic option in participants with this aggressive cancer type. Read Less
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
07/19/2025
Locations: Georgetown University Lombardi Cancer Center, Washington, District of Columbia +29 locations
Georgetown University Lombardi Cancer Center, Washington, District of Columbia
University Cancer and Blood Center LLC, Athens, Georgia
University of Kentucky, Lexington, Kentucky
St. Louis University, Saint Louis, Missouri
Hackensack Meridian Health, Edison, New Jersey
University Hospitals Of Cleveland, Cleveland, Ohio
Fox Chase Cancer Center, Philadelphia, Pennsylvania
Novartis Investigative Site, Innsbruck, Tyrol
Novartis Investigative Site, Montreal, Quebec
Novartis Investigative Site, Montreal, Quebec
Novartis Investigative Site, Bron, Not set
Novartis Investigative Site, Lille, Not set
Novartis Investigative Site, Marseille, Not set
Novartis Investigative Site, Montpellier, Not set
Novartis Investigative Site, Villejuif, Not set
Novartis Investigative Site, Essen, Not set
Novartis Investigative Site, Koeln, Not set
Novartis Investigative Site, Hong Kong, Not set
Novartis Investigative Site, Haifa, Not set
Novartis Investigative Site, Tel Aviv, Not set
Novartis Investigative Site, Napoli, Not set
Novartis Investigative Site, Seoul, Not set
Novartis Investigative Site, Singapore, Not set
Novartis Investigative Site, Barcelona, Catalunya
Novartis Investigative Site, Madrid, Not set
Novartis Investigative Site, Madrid, Not set
Novartis Investigative Site, Madrid, Not set
Novartis Investigative Site, Malaga, Not set
Novartis Investigative Site, Taipei, Not set
Novartis Investigative Site, Guildford, Surrey
Conditions: Extensive Stage Small Cell Lung Cancer
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
Recruiting
This is a Phase III, 2-arm, randomised, open-label, multicentre, global study assessing the efficacy and safety of neoadjuvant Dato-DXd plus durvalumab followed by adjuvant durvalumab with or without chemotherapy compared with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab with or without chemotherapy in participants with previously untreated TNBC or hormone receptor-low/HER2-negative breast cancer.
This is a Phase III, 2-arm, randomised, open-label, multicentre, global study assessing the efficacy and safety of neoadjuvant Dato-DXd plus durvalumab followed by adjuvant durvalumab with or without chemotherapy compared with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab with or without chemotherapy in participants with previously untreated TNBC or hormone receptor-low/HER2-negative breast cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: Research Site, Daphne, Alabama +355 locations
Research Site, Daphne, Alabama
Research Site, Goodyear, Arizona
Research Site, Phoenix, Arizona
Research Site, Tucson, Arizona
Research Site, Jonesboro, Arkansas
Research Site, Rogers, Arkansas
Research Site, Bakersfield, California
Research Site, Fullerton, California
Research Site, Irvine, California
Research Site, Los Angeles, California
Research Site, Los Angeles, California
Research Site, Newport Beach, California
Research Site, Orange, California
Research Site, Santa Barbara, California
Research Site, Santa Rosa, California
Research Site, Sylmar, California
Research Site, Torrance, California
Research Site, Van Nuys, California
Research Site, Aurora, Colorado
Research Site, Fort Collins, Colorado
Research Site, Longmont, Colorado
Research Site, Bridgeport, Connecticut
Research Site, New Haven, Connecticut
Research Site, Newark, Delaware
Research Site, Fort Myers, Florida
Research Site, Jacksonville, Florida
Research Site, Jacksonville, Florida
Research Site, Port Saint Lucie, Florida
Research Site, Saint Petersburg, Florida
Research Site, Tallahassee, Florida
Research Site, West Palm Beach, Florida
Research Site, Atlanta, Georgia
Research Site, Atlanta, Georgia
Research Site, Chicago Ridge, Illinois
Research Site, Dyer, Indiana
Research Site, Des Moines, Iowa
Research Site, Edgewood, Kentucky
Research Site, Louisville, Kentucky
Research Site, Baton Rouge, Louisiana
Research Site, Annapolis, Maryland
Research Site, Boston, Massachusetts
Research Site, Detroit, Michigan
Research Site, Grand Rapids, Michigan
Research Site, Traverse City, Michigan
Research Site, Burnsville, Minnesota
Research Site, Minneapolis, Minnesota
Research Site, Columbia, Missouri
Research Site, Saint Louis, Missouri
Research Site, Omaha, Nebraska
Research Site, Henderson, Nevada
Research Site, Camden, New Jersey
Research Site, East Brunswick, New Jersey
Research Site, New Brunswick, New Jersey
Research Site, Santa Fe, New Mexico
Research Site, Commack, New York
Research Site, New York, New York
Research Site, Charlotte, North Carolina
Research Site, Durham, North Carolina
Research Site, Winston-Salem, North Carolina
Research Site, Blue Ash, Ohio
Research Site, Canton, Ohio
Research Site, Eugene, Oregon
Research Site, Portland, Oregon
Research Site, Horsham, Pennsylvania
Research Site, Philadelphia, Pennsylvania
Research Site, Pittsburgh, Pennsylvania
Research Site, Providence, Rhode Island
Research Site, Chattanooga, Tennessee
Research Site, Nashville, Tennessee
Research Site, Nashville, Tennessee
Research Site, Austin, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, El Paso, Texas
Research Site, Flower Mound, Texas
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Irving, Texas
Research Site, San Antonio, Texas
Research Site, Webster, Texas
Research Site, Fairfax, Virginia
Research Site, Norfolk, Virginia
Research Site, Richmond, Virginia
Research Site, Roanoke, Virginia
Research Site, Winchester, Virginia
Research Site, Tacoma, Washington
Research Site, Madison, Wisconsin
Research Site, Darlinghurst, Not set
Research Site, East Melbourne, Not set
Research Site, Heidelberg, Not set
Research Site, Herston, Not set
Research Site, Nedlands, Not set
Research Site, Waratah, Not set
Research Site, Feldkirch, Not set
Research Site, Graz, Not set
Research Site, Innsbruck, Not set
Research Site, Linz, Not set
Research Site, Salzburg, Not set
Research Site, Antwerpen, Not set
Research Site, Brasschaat, Not set
Research Site, Charleroi, Not set
Research Site, Gent, Not set
Research Site, Leuven, Not set
Research Site, Libramont-Chevigny, Not set
Research Site, Brasilia, Not set
Research Site, Curitiba, Not set
Research Site, Fortaleza, Not set
Research Site, Londrina, Not set
Research Site, Natal, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Ribeirão Preto, Not set
Research Site, Santo Andre, Not set
Research Site, São Paulo, Not set
Research Site, Taubaté, Not set
Research Site, Vitória, Not set
Research Site, Plovdiv, Not set
Research Site, Shumen, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Vratza, Not set
Research Site, Calgary, Alberta
Research Site, Abbotsford, British Columbia
Research Site, Vancouver, British Columbia
Research Site, St. John's, Newfoundland and Labrador
Research Site, Barrie, Ontario
Research Site, London, Ontario
Research Site, Oshawa, Ontario
Research Site, Toronto, Ontario
Research Site, Levis, Quebec
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Sherbrooke, Quebec
Research Site, St-Jerome, Quebec
Research Site, Saskatoon, Saskatchewan
Research Site, Montreal, Not set
Research Site, Ottawa, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Bengbu, Not set
Research Site, Changchun, Not set
Research Site, Changsha, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Harbin, Not set
Research Site, Hefei, Not set
Research Site, Jinan, Not set
Research Site, Kunming, Not set
Research Site, Linhai, Not set
Research Site, Nanchang, Not set
Research Site, Nanchang, Not set
Research Site, Nanjing, Not set
Research Site, Nanjing, Not set
Research Site, Nanning, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Shenyang, Not set
Research Site, Shijiazhuang, Not set
Research Site, Suining, Not set
Research Site, Suzhou, Not set
Research Site, Tianjin, Not set
Research Site, Urumqi, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Xintai, Not set
Research Site, Zhaoqing, Not set
Research Site, Zhengzhou, Not set
Research Site, Avignon, Not set
Research Site, Bayonne, Not set
Research Site, Caen Cedex 5, Not set
Research Site, Clermont Ferrand, Not set
Research Site, Limoges, Not set
Research Site, Lyon, Not set
Research Site, Marseille, Not set
Research Site, Montpellier, Not set
Research Site, Nice, Not set
Research Site, Paris, Not set
Research Site, Reims Cedex, Not set
Research Site, Saint Herblain, Not set
Research Site, Toulouse, Not set
Research Site, Vandoeuvre les Nancy, Not set
Research Site, Villejuif Cedex, Not set
Research Site, Augsburg, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Dessau-Roßlau, Not set
Research Site, Dresden, Not set
Research Site, Erlangen, Not set
Research Site, Essen, Not set
Research Site, Esslingen am Neckar, Not set
Research Site, Frankfurt am Main, Not set
Research Site, Freiburg, Not set
Research Site, Freiburg, Not set
Research Site, Hamburg, Not set
Research Site, Hannover, Not set
Research Site, Hannover, Not set
Research Site, Heidelberg, Not set
Research Site, Kiel, Not set
Research Site, Mainz, Not set
Research Site, Mannheim, Not set
Research Site, München, Not set
Research Site, München, Not set
Research Site, Münster, Not set
Research Site, Trier, Not set
Research Site, Ulm, Not set
Research Site, Hong Kong, Not set
Research Site, Hong Kong, Not set
Research Site, Kwai Chung, Not set
Research Site, Budapest, Not set
Research Site, Kecskemét, Not set
Research Site, Miskolc, Not set
Research Site, Nyíregyháza, Not set
Research Site, Salgótarján, Not set
Research Site, Szekszárd, Not set
Research Site, Bengaluru, Not set
Research Site, Dehradun, Not set
Research Site, Delhi, Not set
Research Site, Delhi, Not set
Research Site, Kolkata, Not set
Research Site, Kolkata, Not set
Research Site, Marg Jaipur, Not set
Research Site, Nagpur, Not set
Research Site, Nashik, Not set
Research Site, Puducherry, Not set
Research Site, Thiruvananthapuram, Not set
Research Site, Vadodara, Not set
Research Site, Empoli, Not set
Research Site, Lucca, Not set
Research Site, Macerata, Not set
Research Site, Milano, Not set
Research Site, Modena, Not set
Research Site, Napoli, Not set
Research Site, Padova, Not set
Research Site, Roma, Not set
Research Site, Rozzano, Not set
Research Site, Torino, Not set
Research Site, Tricase, Not set
Research Site, Udine, Not set
Research Site, Akashi-shi, Not set
Research Site, Akita-shi, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chiba-shi, Not set
Research Site, Chuo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Fukushima-shi, Not set
Research Site, Gifu-shi, Not set
Research Site, Hidaka-shi, Not set
Research Site, Hirakata-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Isehara-shi, Not set
Research Site, Kashiwa, Not set
Research Site, Koto-ku, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Kurume-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Matsuyama-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Niigata-shi, Not set
Research Site, Okayama, Not set
Research Site, Osaka-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Shinagawa-ku, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Sunto-gun, Not set
Research Site, Tsu-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Daegu, Not set
Research Site, Goyang-si, Not set
Research Site, Seongnam, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, George Town, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuching, Not set
Research Site, Selangor, Not set
Research Site, Bialystok, Not set
Research Site, Bydgoszcz, Not set
Research Site, Gdańsk, Not set
Research Site, Gdynia, Not set
Research Site, Kraków, Not set
Research Site, Tomaszów Mazowiecki, Not set
Research Site, Warszawa, Not set
Research Site, Wroclaw, Not set
Research Site, Łódź, Not set
Research Site, Singapore, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, Granada, Not set
Research Site, Hospitalet deLlobregat, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Santiago de Compostela, Not set
Research Site, Sevilla, Not set
Research Site, Zaragoza, Not set
Research Site, Baden, Not set
Research Site, Basel, Not set
Research Site, Bern, Not set
Research Site, Frauenfeld, Not set
Research Site, Genolier, Not set
Research Site, Rennaz, Not set
Research Site, Changhua, Not set
Research Site, Kaohsiung, Not set
Research Site, Taichung, Not set
Research Site, Tainan, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Dusit, Not set
Research Site, Muang, Not set
Research Site, Songkhla, Not set
Research Site, Adapazari, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Istanbul, Not set
Research Site, Kayseri, Not set
Research Site, Samsun, Not set
Research Site, Birmingham, Not set
Research Site, Cardiff, Not set
Research Site, Edinburgh, Not set
Research Site, Guildford, Not set
Research Site, Lancaster, Not set
Research Site, London, Not set
Research Site, Northampton, Not set
Research Site, Oxford, Not set
Research Site, Taunton, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh city, Not set
Research Site, Vinh, Not set
Conditions: Breast Cancer
25 - 36 of 335